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L1 Larva stage 1 
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OD Optical density 
PAGE Poly acrylamide gel electrophoresis 
ROS Reactive oxygen spicies 
RT-PCR Real time polymer chain reaction 
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VII Summary 
The molecular adaptation of S.aureus to copper Schiff’s base (CSB) was studied by 
comparative proteome analysis. Proteome analysis was performed by employing 
nano LC-MALDI mass spectrometry with isobaric tags (iTRAQ) and 2D-DIGE 
techniques. In CSB adapted MSSA476 (ErCu), considerable decrease in Cu ion 
concentration and copZ protein is observed as compared to non-CSB adapted 
MSSA476 strain by ICP-MS and nano LC-MALDI experiments respectively. CopZ 
protein is a copper transport protein, which aids the export of Cu+ across the 
membrane. Decreased Cu+ and CopZ suggest reduced Cu+ influx in to the cell. It 
has been already established that repression of Putative septation protein SpoVG 
leads to repressed biofilm formation in S. aureus. Approximately two fold increase in 
SpoVG in CSB adapted MSSA476 as observed by 2D-DIGE experiment suggests 
enhanced ability for biofilm formation in the adapted strain. Enhanced biofilm 
formation is further confirmed by biofilm assay experiment. Contrary to popular 
belief, it has been demonstrated previously that repression of accessory gene 
regulatory (agr) system is necessary to form a biofilm. Repression of agr system is 
confirmed by reduced agrA protein observed by nano LC-MALDI experiment in 
ErCu. Because of the agr repression, reduced virulence in ErCu strain was 
demonstrated and was further confirmed by virulence analysis experiments on 
C.elegans. SpoVG is known to be positively regulated by sigmaB factor; on the other 
hand sigmaB has a negative effect on agr sytem. Therefore, sigmaB can be 
proposed as a common factor, which is involved in the interrelation of SpoVG 
expression and agr system expression in ErCu. However, the proteomics analysis 
was not able to conclusively determine the expression of sigmaB incase of ErCu. 
Nevertheless, up-regulation of SpoVG and down-regulation of agr system in ErCu 
Summary 
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were proved beyond doubt, which facilitates enhanced biofilm formation in ErCu. The 
extracellular matrix of S.aureus biofilm is known to immobilize toxic metals by ionic 
interaction of opposite charges (DNA), by precipitation, biosorption etc. It has been 
established that enhanced biofilm formation is the likely cause of oxidative stress 
tolerance towards excess copper concentration in this strain. It can be proposed that 
CSB adapted MSSA476 has developed a mechanism to increase biofilm formation 
which prevents excess Cu+ influx in to the cell and therefore prevents excess 
oxidative stress exerted by excess Cu+ within the cell. It is demonstrated that 
MSSA476 required only few generations to achieve tolerance to inhibitory 
concentrations of CSB due to enhanced biofilm formation properties. This 
emphasizes once again the importance of dealing with biofilms as a prime target for 
S.aureus therapies. 
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1. Introduction
1.1 Background 
In our study, we were interested in the generation of evolutionary resistance in 
bacteria and characterisaton of the response at the proteome level. Therefore, 
we used methicilin susceptible Staphylococcus aureus 476 strains (MSSA476) as 
a prototype for a clinically relevant bacterial strain and a novel antibacterial 
substance Copper Schiff’s Base (CSB) synthesised by N. Poulter et al., 
University of Bath, UK (1). 
Figure 1: Molecular structure of CSB (bis(N-allylsalicylideneiminato)-copper). 
(Artwork from N. Poulter et al. (1)) 
Staphylococcus aureus (S. aureus) is an opportunistic gram-positive bacterium that 
is responsible for a spectrum of diseases including endocarditis, wound infections, 
meningitis, pulmonary infections, toxic shock syndrome (2-6). Its ability to adapt and 
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develop resistance to the antibiotics makes the organism one of the most successful 
pathogens (7-9). 
Several factors are known to be related to anti-microbial resistance in S.aureus 
especially with respect to antibiotic resistance. In case of vancomycin and 
teicoplanin glycopeptides antibiotic resistance in S.aureus, thickening of cell wall 
prevents the antibiotics to diffuse in to the division septum of the cell to achieve 
resistance (10-12). YabJ-spoVG operon is known to control resistance of 
glycopeptides antibiotics in S.aureus (13, 14). Putative sepatation protein SpoVG 
(not yabJ) controls the regulation of the operon (15). SpoVG is known to be involved 
in the barrier septum assembly (www.uniprot.org) and capsule formation (16). 
Eventhough exact underlying molecular mechanism of cell wall thickening in 
antibiotic resistance is unknown, role of SpoVG can be suspected. Some antibiotic 
resistance is also seen in ‘accessory gene regulatory’ (agr) system deficient S. 
aureus strains (17). Agr system controls the quorum sensing and related virulence 
factors in S.aureus (18). S.aureus employs agr mediated quorum sensing to control 
virulence factor expressions based on to the signals received due to on cell density 
and environmental changes (19, 20). Agr system consists mainly of 4 factors: agrA, 
agrB, agrC and agrD. Based on cell density and environmental changes agrB and 
agrD produce and excrete ‘Auto inducing peptides (AIP)’, which is a signal molecule 
of agr. At higher concentrations of AIPs, AIP binds to agrC and triggers agrA by His-
dependent phosphorylation. AgrA in turn, induces the expression of RNAIII and 
RNAII transcripts of agrA, agrB, agrC and agrD to establish a feedback loop (21-23). 
On the other hand, RNAIII induces the extracellular virulence facors by repressing 
the cell wall related proteins (24, 25). Therefore, in resistant, agr deficient S.aureus, 
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evidences for reduced extra cellular virulence factors can be observed (17) and 
increased cell wall associated proteins like those that SpoVG can be expected. 
Resistant strains tend to have a fitness advantage over non resistant strains in 
presensce of antibiotic stress and because of the fitness advantage, bacteria 
survives when the environmental pressure is exerted, perhaps at the cost of reduced 
virulence gene expression (23, 26-28). Eventhough in presence of antibiotics 
reduced virulence factor expressions may serve no advantage to the bacteria itself at 
first, it is required to survive and attain a certain cell density to establish infection with 
in the host system (23, 28). 
Clumping factor A (clfA), immunoglobulin G-binding protein a (spa), are adhesion 
virulence factors located on the cell wall and are released extra cellularly 
establishing infection in the the host system (www.uniprot.org) (29). As mentioned 
above, when the antibiotic stress is applied on S.aureus, stress resistant S. aureus 
survives because of it’s fitness advantage at the cost of reduced virulence factors 
(23, 26-28). Therefore, reduced expression of clfA and spa are expected in antibiotic 
stress resistant S.aureus. 
Biofilm formation is another factor, which is often associated with ant-microbial 
resistance in bacteria. It has been established that increased biofilm formation leads 
to enhanced oxidative stress tolerance in bacteria (30-32). SpoVG and agr are 
shown to play a role in biofim formation in S.aureus. (33-38) (39). 
Because of the ability of S.aureus to quickly adapt and bring resistance to a range of 
antibiotics, the treatment of infectious diseases caused by S. aureus is becoming a 
major problem in health care. Hence, the incidence of infectious diseases has 
increased significantly (40-42) . Therefore, there is always a demand for more 
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effective and safer chemotherapeutic agents. It is known that heavy metals can be 
good candidates for the therapeutic agents. Metal coordination complexes have 
been widely studied for their antimicrobial properties (43) (44). This has given a 
scope for the research of new metal complexes as bioactive compounds. 
Benefits of different copper complexes against diseases such as tuberculosis, 
rheumatoid arthritis and infectious diseases have been demonstrated (45) (46). The 
treatment with copper complexes containing nitrogen and oxygen donor ligands 
show significantly better pharmacological effects than the regular inorganic forms of 
copper (47). The complexes also show stronger antimicrobial activity than the free 
ligands (48). Copper complexes using Schiff’s base ligands are of major interest 
because of their biological importance (49). In this study the resistance mechanism 
of S. aureus against copper Schiff’s base (bis (N-allylsalicylideneiminato)-copper) 
(synthesized and provided by N. Poulter et al. at University of Bath, UK) (1) was 
studied. Plasma deposited copper Schiff’s base complex (CSB) can be used as an 
antimicrobial coating (1). Such coatings on various objects like fabrics, clinical tools 
like catheters can help to solve the infection related issues in our day-to-day life. It 
was also shown that Schiff’s base alone can be antimicrobial as well; however the 
concentration of Schiff’s base required to exert stress on S. aureus cells is much 
higher than the concentration of CSB that has been used by N. Poulter et al. (1). 
It is a known fact that S. aureus has the ability to adapt quickly to different conditions 
and thus survive in adverse conditions such as stress by heavy metals (50). It has 
been shown that the presence of genes encoded by plasmid confer resistance to 
heavy metals like cadmium and mercury (51). It has also been described that the 
presence of the plasmid is not necessary to develop resistance to some other heavy 
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metals like zinc, copper, cobalt (52). Some of these heavy metals are essential for 
the cells to survive but only in trace amounts. So far, not much is known about the 
molecular mechanisms of adaptation to increased cellular heavy metal 
concentrations. 
Copper is needed for many metabolic processes taking place in the cells e.g. the 
electron transport chain (53) (54) but only in trace amounts. It has been shown that 
an increase in the copper level beyond the physiological limits can be toxic to the cell 
(55). But when a constant pressure is created by the heavy metals like copper in the 
bacterial environment, it leads to selection of new variant bacterial strains which are 
resistant to the heavy metals (56, 57). So it becomes important to understand the 
mechanism by which S. aureus evolves and adapts to the pressure created by the 
copper complexes.  
1.2 Methodology 
Our study is focused on understanding the quantitative and qualitative changes of 
the proteome and corresponding gene expressions in a microevolved MSSA476 
strain, which is resistant against antibacterial CSB complex (ErCu strain). The study 
of the proteome changes in ErCu strain helps to investigate the molecular 
mechanism of the adaptation of MSSA476 against CSB. This study was further 
extended to investigate the virulence of the resistant strain on the host 
Caenorhabditis elegans (C.elegans). 
For the comparison of the complete proteome of MSSA476 and ErCu strain, 2- 
Dimentional Differential In Gel Electrophoresis (2D-DIGE) and nano Liquid 
Chromatography –Matrix Associated Laser Desorption Ionisation (nano LC-MALDI) 
with isobaric tags for relative and absolute quantitation (iTRAQ) was used. 2D-gel 
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electrophoresis is a technique used to resolve individual proteins from a complex 
protein cocktail. The resolution of proteins is based on their respective isoelectric 
points and molecular weights. 2D-DIGE is a 2D gel electrophoresis technique, which 
uses fluorescent dyes (CyDyes) to label the proteins. CyDye labelling with multiple 
dyes (Cy2, Cy3, Cy5) allows to run the proteome from the multiple sources on the 
same gel. The individual proteome pattern on the gel can be compared with each 
other up on scanning the gel with the respective CyDye wavelengths. In this study, 
Cy3 and Cy5 dyes (GE Healthcare, Upsala, Sweden) were used to compare 
proteome of MSSA476 and ErCu strain and typhoon scanner (GE Healthcare, 
Upsala, Sweden) was used to scan the gels. 
First dimentional protein separation is a horizontal separation of proteins based on 
their respective isoelectric point. The process is also known as iso electric focusing 
(IEF). IEF resolved proteins are further subjected to second dimentional vertical 
separation of proteins based on their molecular weight. Based on the internet 
sources (http://www.appliedbiomics.com/support/2d-dige-vs-2d-gel.html) and 
protocols published by A. Görg and collegues (Two-Dimensional Electrophoresis 
with Immobilized pH Gradients for Proteome Analysis; A laboratory manual, 
www.wzw.tum.de/proteomik), the advantages of fluorescent labeling over regular 2D 
gel electrophoresis are listed below. 
Higher sensitivity:  CyDye labeling gives sensitivity of 0.2ng/spot. This allows us to 
use smaller amounts of protein sample. 
High accuracy: Differences in protein expression up to 10% can be detected. 
Fluorescent labeling allows software aided accurate quantification of proteins. 
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Cost and time effectiveness: CyDye labeling allows multiple protein samples run on 
a same gel, this allows fewer number of gel runs per study. This also allows fewer 
number of gel runs for the statistical analysis. 
Nano LC-MALDI analysis is based on differential labelling of N-terminus of the 
peptides by isobaric tags. Tagged samples are further analysed by tandem mass 
spectrometry for the relative quantification (58) and it is expected to provide wider 
range of protein data as compared to 2D gel electrophoresis due to the employment 
of isobaric tags for the relative and absolute quantification of peptides and Liquid 
chromatography technique for the resolution of peptides from the complex protein 
mixture. 
For comparative proteomics analysis, both 2D-DIGE and nano LC-MALDI technique 
were used to achieve the best results possible. 
1.3 Motivation 
This research thesis was part of research project called EMBEK1, which was funded 
by the European Research Council (ERC). The aim of EMBEK1 was to develop 
antimicrobial surfaces usable in medicine. For fabrication of such surfaces novel 
anti-microbial monomers, this can be used for plasma assisted vapour depositon to 
coat various surfaces in health care. As some of the surfaces, such of implants, 
surgical knives, sutures, catheters, do come in contact with the patient’s body, the 
criteria of selecting an anti-microbial substance is mainly based on 2 factors. 1) 
Strong anti-microbial property and 2) compatibility with human cells/tissues. In 
copper Schiff’s base complex, N. Poulter et al. at University of Bath, UK (1) 
developed a substance, which passes both the criteria. 
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There are ever increasing reports of evolution of bacterial resistance against anti-
microbial substances in health care domain. EMBEK1 addresses the problem by 
aiming to improve the design of the chosen anti-microbial substances like copper-
Schiff’s base complex (CSB). To better the design of anti-microbial substance, this 
study attempts to understand the molecular mechanisms involved in the adaptation 
of pathogenic bacteria like S.aureus to anti-microbial substance like CSB. 
To achieve the insights in to the molecular mechanism involved in the adapatation of 
S.aureus to CSB, comparative proteomics study was performed, as protein is the 
executive apparatus of the cell. It is more complex and closer to function of a 
biological system than the gene.  Most of the previous studies on the issue are 
mostly focused at the genome level and on the knock out strains. But with this study 
we not only aim to gain the proteomic insights in to the adaptation mechanism of 
micro evolved S. aureus strain against heavy metal ions like copper ions, but we also 
aim to translate the proteomics data in to one broad unifying theory at a physiological 
level with the help of state of the art iTRAQ labeled nano LC- MALDI analysis and 
2D-DIGE analysis to analyse complete proteome of the micro evolved bacteria (S. 
aureus), whereas most of the previous proteomic studies relied only on 
comparatively primitive techniques like 2D-Gel Electrophoresis. 
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2. Materials
2.1 Chemicals 
Acetonitrile (Sigma-Aldrich) 
Agar (Fluka) 
Amonium sulphate (≥98%, Roth) 
CaCl2 (≥98%, Roth) 
CHAPS (GE Healthcare, Uppsala, Sweden) 
Cholesterol (≥ 99%, Sigma-Aldrich) 
Coagulase disc (Fluka) 
Colloidal coomassie blue G-250 (GE Healthcare, Uppsala, Sweden) 
Copper Schiff’s base (CSB) (University of Bath, UK) (59) 
Crystal violet (Sigma-Aldrich) 
 Dimethylsulfoxide (DMSO) (≥ 99.9%, for molecular biology, Sigma-Aldrich) 
Dithiothreitol (DTT) (99.0%, PlusOne, GE Healthcare) 
Ethanol (Merk KGaA) 
Ethidiumbromide (Sigma-Aldrich) 
Formic acid ((Sigma-Aldrich)  
Glycerol (85 % PlusOne, GE Healthcare) 
Hydroethidine (Sigma-Aldrich) 
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K2HPO4 (≥ 98.0%, Carl Roth) 
KH2PO4 (≥ 99.0%, Carl Roth) 
LB Agar (Luria/Miller) for molecular biology (Carl Roth) 
LB medium (Luria/Miller) for molecular biology (Carl Roth) 
Lysostaphin (5mg/ml, Sigma-Aldrich) 
Methanol (HPLC grade, Carl Roth) 
MgSO4 (Ultra pure, Carl Roth) 
Na2HPO4 (> 99.0%, Roth) 
NaCl (Merk, extra pure) 
Nucleases (Sigma-Aldrich) 
Nystatin suspension (10,000 units/ml, Sigma-Aldrich) 
Peptone from casein, tryptic digests (Fluka) 
Pharmalyte (GE Healthcare, Uppsala, Sweden) 
Protease inhibitor (Sigma-Aldrich) 
Sodium dodecyl sulphate (SDS) (99.0%, Carl Roth, PlusOne, GE Healthcare) 
Thiourea (Carl Roth) 
Triethylammonium bicarbonate (TEABC) (Sigma-Aldrich) 
Tris (99.9%, Carl Roth, PlusOne, GE Healthcare) 
Tween 20 (Carl Roth) 
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Ultra pure water  
Urea (PlusOne, GE Healthcare) 
2.2 Kits and special reagents 
2D-clean up kit GE Healthcare, Uppsala, Sweden 
2D-quant kit GE Healthcare, Uppsala, Sweden 
ampholytes pH 4–7 GE Healthcare, Uppsala, Sweden 
RevertAid H Minus 
First Strand cDNA 
synthesis kit 
 Thermo Fisher Scientific, 
Germany 
CyDye™ DIGE Fluor GE Healthcare, Uppsala, Sweden 
minimal labelling kit 
IPG strips GE Healthcare, Uppsala, Sweden 
iTRAQ reagents (114 , 116) AB Sciex, 
Germany 
RNA isolution 
kit 
Quiagen universal tissue kit, 
Germany 
Sybgreen dye Abi Prism 7000, Applied 
Biosystems, Germany 
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2.3 Special solutions and buffers 
Bromophenol blue stock solution 
1% bromophenol blue (w/v), 50mM tris-base volume made up by double distilled 
water. 
Colloidal coomassie blue G-250 dye stock solution 
50g ammonium sulphate, 6 ml phosphoric acid 85% (w/w), 10 ml 5% coomassie blue 
G-250 stock made up to 500 ml with double distilled water. 
Lysis buffer for nano LC-MALDI proteomics analysis 
 4% SDS, 0.1M DTT and 30mM Tris HCl (pH 7.5) 
M9 buffer 
0.02M KH2PO4, 0.04 M Na2HPO4, 0.08M NaCl (autoclave for 20 min at 121°C), add 
1 ml 1M MgSO4 
NGM media 
2.5 g/l bacto peptone, 3 g/l NaCl, 17 g/l agar (autoclave at 121°C for 20 min). In 
sterile condition add 10 ml 0.1 M CaCl2, 10 ml 0.1 M MgSO4 and 1 ml 5mg/ml 
cholesterol,  2.5 ml 10000 units/ml nystatin, make the volume to 1L  by adding 25 ml 
of 1 M sterile phosphate buffer,  pH 6.0. 
Rehydration solution for 2D-DIGE analysis 
7M Urea, 2M thiourea, 2% (w/v) CHAPS, 0.5% pharmalyte , 0.002% bromophenol 
blue, double distilled water. 7 mg/ 2.5 ml DTT added just prior to use. 
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2.4 Organisms used 
Caenorhabditis elegans ( NCBI taxonomy ID: 6239)  
Provided by : Prof. Dr. Björn Schumacher,CECAD Forschungszentrum, Cologne, 
Germany. 
Escherichia coli OP50 (NCBI taxonomy ID: 637912) 
Provided by : Prof. Dr. Björn Schumacher,CECAD Forschungszentrum, Cologne, 
Germany. 
ErCu (Evolutionarily resistant to copper MSSA476) 
Prepared by : Vishwas Kaveeshwar, University of Bonn, Bonn, 
Germany. Currently, stored in Institute for Rechtsmedizin, University 
Clinic Cologne, Germany. 
Methicilin Sensitive Staphylococcus aureus 476 (NCBI taxonomy ID: 282459) 
Provided by Dr. Toby Jenkins, University of Bath, Bath, United 
Kingdom. 
Staphylococcus carnosus ( NCBI taxonomy ID: 147448)  
Provided by Prof.Dr.E.A.Galinski, IFMB, University of Bonn, Germany. 
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3. METHODS
3.1 Evolution of CSB resistance in MSSA476 
Ten μL of an overnight culture of MSSA476 were inoculated in 6 ml LB medium with 
different concentrations of CSB in culture tubes. The tubes were incubated at 37°C 
for 18 h. After incubation, the optical density (OD) at 600 nm was determined. 
Resistance against CSB was achieved by passaging the cultures using LB medium 
containing final concentration of 0.6 mM CSB (concentration at which the culture 
shows 95% inhibition with respect to the control (MIC 95). 6 tubes of 6 ml LB 
medium with MIC95 of CSB (final concentration 0.6 mM dissolved in LB medium 
containing 1% DMSO) were inoculated with 60 μL of MSSA476 (1% of culture 
inoculation) and incubated for 18 h at 37°C. After 18 h the cultures were passaged 
into 6 fresh tubes containing 6 ml of LB with MIC95 of CSB. The tubes were 
incubated again at 37°C for 18 h. After 6 passages (Approx. 135 generations) the 
cultures had grown to optical densities of 6 at 600nm. These cultures were plated out 
on LB agar plate, which contained 0.7 mM CSB. After the incubation at 37°C 
overnight, a single colony was picked and passaged again in an overnight culture at 
37°C in 6 ml LB mixed with 0.7 mM CSB. This stock was again passaged in LB 
containing 0.8 mM CSB overnight at 37°C. Tolerance against 0.8mM CSB was 
achieved in approximately 7 days. The adapted cultures were stored in 20% (v/v) 
Glycerol at - 80°C until use for further experiments. We called the adapted strain 
‘ErCu’. 
3.1.1 Microevolved S.aureus strain confirmation 
To check for the contaminations, and to confirm that microevolved cultures are still 
S.aureus, PCR experiment was performed to detect nuc gene. Presence of nuc gene 
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was tested in MSSA476 (Positive control), microeveolved ErCu and Staphylococcus 
carnosus (Negative control). PCR experiment was performed as per the protocol 
published by Brakstad et al (60) with the modified  conditions and settings as 
mentioned below. 
Amplification of the gene was performed in over all of 40 cycles. 
• 95ºC  for 5 min.
• 20 s at 95ºC, annealing for 45s starting at 63ºC and decreasing by 0.5ºC.  For
each of the susequent 19 cycles, followed by extension of 72ºC.  . 
• 20 s at 95ºC, 45 s at 56ºC and 45 s at 72ºC  for remaining 20 cycles.
• Amplified products detected by 1.5% agarose gel electrophoresis.
The microevolved cultures were further grown on LB Agar and mannitol salt agar 
(Fluka) to check the contamination. Only when microevolved cultures were 
confirmed that the cultures are essentially still S.aureus with PCR experiments and 
mannitol agar test the cultures were further processed. Single colony of Ercu grown 
in mannitol agar media was picked and cultured for further experiments. 
3.2 Characterisation of ErCu strain 
 3.2.1 Intracellular superoxide anion measurement 
Superoxide dismutase (SODM), which is a marker of oxidative stress, catalyses 
detoxification of superoxide anion to H2O2 which is further broken down to H2O by 
the enzyme catalase (61, 62). 
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Measurement of superoxide anion was performed using hydroethidine (HE) (63). 
Superoxide anions formed by the bacterial cell metabolism oxidize HE to ethidium 
bromide (EB) (64) which can be detected and quantified. 
Two hundred µl of an overnight culture of MSSA476 and CSB adapted MSSA strains 
with the OD of 6 were inoculated in 20 ml LB medium separately. The cultures were 
grown to the same OD of 3 at 600nm. 200 µl of each culture were transferred to a 96 
well micro titre plate, then final concentration of 0.5 mM of CSB and final 
concentration of 10µM HE were introduced to the culture containing wells. Both 
cultures were further incubated for another 30 min. At this point EB fluorescence was 
scanned using typhoon trio scanner (GE Healthcare) at 488 nm excitation and 610 
band pass filter, data was further analysed using Image Quant TL 7.0 (GE 
Healthcare). MSSA476 and ErCu strains, which were not incubated with 0.5 mM 
CSB, were also analysed for EB fluorescence and used to normalise the EB 
fluorescence in MSSA476 and ErCu strains, which were incubated with 0.5 mM CSB 
3.2.2 Cellular copper concentration measurement 
Two hundred µl of an overnight culture of MSSA476 and CSB adapted MSSA strains 
with the OD of 6 are inoculated in a flask each of 20 ml LB medium separately. The 
cultures were then incubated at 37°C for 4 hours. After 4 hours, 0.5 mM of CSB was 
introduced to all the test tubes. The cultures were further incubated for another 30 
min. At this point cultures were harvested which are in the log phase and are grown 
to the same OD of 3 at 600nm. Reference cultures were also prepared in the same 
way, but the cultures were not intoxicated with CSB. The media was devoid of any 
external copper. 
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All the bacterial pellets, which were harvested including reference culture, were 
washed 3 times with the phosphate buffer. Pellets were subjected for vacuum drying. 
Once the bacterial pellets were completely dried, green coloured copper residue 
which is attached to the surface of the pellet was removed manually and discarded. 
Equal amounts of dry pellets (5.6 mg) were taken for the further analysis. The dry 
pellets were re-suspended in 150 µl of 100µg/ml lysostaphin and incubated for 10 
min at 37°C. Each of the suspensions was made up to 1 ml with 30mM Tris HCL (pH 
7.5). Suspensions were boiled at 100°C for 15 min. Copper measurement in 
MSSA476 strain, ErCu strain and reference was performed using inductively coupled 
plasma mass spectrometry (ICP-MS) according to the protocol published by A. Lotz 
et al.(65). Actual ICP-MS measurement was performed by Dr. A. Lotz, Max Planck 
Institute for Polymer Research, Mainz, Germany. 
3.2.3 Phenotypic expression of virulence factors in MSSA476 and in ErCu 
3.2.3.1 Slide coagulase test (test for clumping factor) 
The test was performed with MSSA476 strain as a positive control sample, ErCu 
strain, Staphylococcus carnosus (S. carnosus) as a negative control on 3 different 
glass slides each. One drop of ultra pure water was given onto a glass microscope 
slide. A high concentrated suspension of the respective organism was then 
prepared. One coagulase disc (Fluka) was added and rubbed on the suspension 
with the tip of an inoculation loop. Subsequently, a second drop of ultra pure water 
was added and mixed again. 
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3.2.3.2 Blood agar test 
LB agar containing 5% human blood was prepared. Overnight cultures of MSSA476 
and evolutionary ErCu strains were plated out on the prepared blood agar medium 
and incubated at 37° C for 18 h. 
3.2.3.3 Virulence test of ErCu in comparison with MSSA476 strain on 
Caenorhabditis elegans 
C. elegans life cycle contains 4 larval stages (Fig. 2). At 25ºC, it takes approximately 
24 h to attain L4 stage from L1 stage. When there is food deficiency, starving larvae 
go in dauer phase. After supplying the food, dauer larvae will reach L4 stage. In 
C.elegan growth assay, the number of survived L4 staged larvae was determined, 
when L1 stage larvae were inoculated on a lawn of MSSA476 and ErCu strain in a 
given time. 
Figure 2: Life cycle of a C.elegan at 25 ºC (From Miranda Klees et al., 
Department of Biological Sciences, Clemson University, United States of 
America, artwork from www.scq.ubc.ca/geneUc‐studies‐of‐aging-
and‐longevity‐in‐model‐organisms) 
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A lawn of MSSA476, a lawn of ErCu strain and a lawn of E. coli op 50 (control, 
nutrition factor of C. elegans) were grown on nematode growth medium (NGM) 
plates. Plates with MSSA476 were used as positive control (inhibition of C. elegans 
growth is expected) and E.coli op 50 as a negative control (no inhibition of C. 
elegans   growth is expected), respectively.  
A plate of fully starved C. elegans was washed with 10 ml of M9 buffer. The collected 
buffer fraction containing the C.elegans was then filtered through a nylon filter (NY11 
Milipore, 11 μm) and the L1 stage C. elegans containing filtrate was collected in 
falcon tubes. 500 µl of the filtrate was used to culture the C. elegans on each 
bacterium inoculated NGM plate. Each plate contained 20 L1 staged C. elegans. All 
three plates were incubated at 25°C for 24h. No L4 staged C.elegans were found 
either in MSSA476 or in ErCu. C.elegans were further incubated for another 24h at 
25ºC. In this time, healthy nematodes grow into L4 stage. After 48 h all three plates 
were examined under the microscope and the number of L4 staged C. elegans was 
counted. The experiment was repeated 3 times. 
3.3 Comparative studies between MSSA476 and ErCu with respect to protein 
and gene expression 
3.3.1 Two-Dimentional Differential In Gel Electrophoresis analysis 
Two-hundred µl of an overnight culture of MSSA 476 and CSB adapted MSSA 
strains with the OD600 of 6 were inoculated in 20 ml LB medium separately. The 
cultures were then incubated at 37°C for 4 h. After 4 h 0.5 mM of CSB was 
introduced to all test tubes. Both the cultures were further incubated for another 30 
min. The cultures were harvested by centrifugation at an OD just above 3 at 600nm 
(log phase). 
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Both the bacterial pellets were washed at least 3 times with phosphate buffer. Pellets 
were re-suspended in 1 ml lyses buffer (7 M urea, 2 M thiourea, 30 mM TRIS (pH 
7.5), 4% v/v CHAPS) and subjected to a pressure of 2.70 lbs/m2 in the Constant cell 
disruption system. After the lysis, the samples were incubated at 37°C for 15 min 
containing a final concentration of 1 x nuclease mix and 1 x protease inhibitor. 
Further, proteome analysis of ErCu and MSSA476 strains was performed mostly 
according to the protocols from A. Görg and collegues (Two-Dimensional 
Electrophoresis with Immobilized pH Gradients for Proteome Analysis; A laboratory 
manual, www.wzw.tum.de/proteomik). Some modifications were made as mentioned 
in the protocol published by P. Cierniak et al (66). The samples were centrifuged at 
8000 g for 20 min at 4°C to remove insoluble material after incubation. The 
supernatant was then transferred into 1.5 ml centrifuge tubes and centrifuged again 
at 25000 g for 45 min at 4°C. Subsequently, proteins were isolated from the crude 
extracts by the 2-D Clean-Up Kit (GE Healthcare, Uppsala, Sweden) according to 
manufacturer's instructions and dissolved in lysis buffer (7 M urea, 2 M thiourea, 4% 
(v/v) CHAPS, 30 mM tris (pH 7.5)). The pH of the dissolved samples was adjusted to 
8.5 on ice with 0.1 M NaOH (analytical grade, Carl Roth, Karlsruhe, Germany) and 
the protein concentration was photometrically determined using the 2-D Quant kit 
(GE Healthcare, Uppsala, Sweden). 
 The protein samples were then CyDye labelled. 50 µg of protein from each sample 
was labelled using the CyDye™ DIGE Fluor minimal labelling kit (GE Healthcare, 
Uppsala, Sweden) as suggested in the manufacturer's instructions. 1.1 µl of Cydye 
was used to label the 50µgs of protein each.  After labelling, sample buffer (7 M 
urea, 2 M thiourea, 4% (v/v) CHAPS, 2% (v/v) ampholytes pH 4–7) was added to the 
labelled protein sample in the ratio of 1:1 and pooled. Each pooled sample consisted 
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of an array of the non-adapted MSSA 476 proteome, an array of the adapted ErCu 
proteome and a mixture of all samples (internal standard). The dye labelling order 
was reversed from one sample to the next. The swapping of dyes balances the effect 
of label factor and permits ANOVA (Analysis of Variance) estimation. The samples 
were then subjected to Iso electric focusing (IEF). 
IEF was performed on an immobilized pH gradient (IPG) 18 cm strips, pH 4–7 (GE 
Healthcare, Uppsala, Sweden). Dry IPG 18cms strips were rehydrated over night in 
rehydration solution. The samples were then applied at the cathode end onto IPG 
strips using cup loading method (GE Healthcare, Uppsala, Sweden). IEF separated 
samples were further subjected for the additional separation in the second dimension 
(Ettan DALTsix, GE Healthcare, Uppsala, Sweden) for 5 h. SDS PAGE gel on which 
second dimensional separation was performed is scanned using a fluorescent 
scanner (Typhoon Trio, GE Healthcare, Uppsala, Sweden). Three different 
wavelengths corresponding to the Cydyes, with associated band pass filters, were 
used to scan the gels. Experimental groups were analysed by DeCyder™ V6 (GE 
Healthcare, Uppsala, Sweden). Protein spots with Student’s T-test score p<0.01, 
false discovery rate correction (q<0.01) were considered and picked for the further 
mass spectrometry analysis. Null hypothesis for these proteins was rejected.  Once 
the protein spots which are significantly differentially expressed were identified, the 
spots were manually picked from the colloidal coomassie blue (GE Healthcare, 
Uppsala, Sweden) stained 2DE gels. These gels were run parallel to 2D-DIGE gels. 
The gels were prepared and stained as per the instructions from the manufacturers. 
The picked protein spots were further digested by trypsin and the resulting peptides 
were analysed using ultra high performance liquid chromatography-mass 
spectrometry. Further MS analysis is performed according to the protocol explained 
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by P. Cierniak et al. (66) by Dr.Stephan Mueller at the Center for Molecular Medicine 
Cologne, University Hospital Cologne, Germany. 
3.3.2 Nano LC- MALDI analysis 
3.3.2.1 Bacterial growth conditions and sample preparations 
Two-hundred µl of an overnight culture of MSSA476 and ErCustrains with the OD of 
6 were inoculated in 3 flasks each of 20 ml LB medium separately. The cultures were 
then incubated at 37ºC for 4 hours. After 4 hours, CSB was introduced to all test 
tubes making the final concentration of the CSB to 0.5 µM and then all 6 cultures 
were further incubated for another 30 min. As next step, the cultures were harvested 
by centrifugation at an OD of 3. All the bacterial pellets were washed 3 times with 
phosphate buffer. Both adapted and the non-adapted strains were re suspended in 
150 µl of 100µg/ml lysostaphin and incubated for 10 min at 37°C. Afterwards the 
suspension was subjected to ultra sonication (Bandelin). Four percent Sodium 
dodecyl sulfate (SDS) and 0.1 M Dithiothreitol (DTT) (final concentration) were 
added to each of the crude extracts and the suspensions were made up to 1 ml with 
30mM Tris HCl (pH 7.5). Suspensions were boiled at 100°C for 15 min to lyse the 
cells completely. A mild centrifugation step of 3000 g for 5 min was performed. The 
resulting pellets were discarded and the supernatants, which contain the proteins, 
were analysed with the nano LC- MALDI mass spectrometry. 
3.3.2.2 Filter assisted sample preparation (FASP) 
FASP was performed on crude lysates to obtain tryptic digested peptides for LC-MS 
experiments as per the protocols of J.R Wisniewski et al. (67) with some minor 
modifications. Lysates were centrifuged at 14.000 rcf for 5 min at 20°C. 20 µl of the 
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supernatants corresponding to 60 µg protein were transferred to Amicon Ultra 
centrifugal filter units (0.5 ml, 10K). FASP was performed by using 1 µg of sequential 
endoproteinase Lys C. In addition, 1 µg of trypsin was used for the peptide digestion 
as demonstrated by Wisniewski JR et al. (67). In all the buffers used, TrisHCl with 
the concentration of 0.1 M was replaced by 0.1 M triethylammonium bicarbonate pH 
8.5 (TEABC). However, in initial lysis buffer, buffer replacement is avoided. After the 
digestion, centrifugation of digested samples was performed and resulting filtrates 
were collected. 120 µl of 10% acetonitrile in ultrapure water were added to the 
filtrate, mixed with the residual sample and centrifuged again. Thus, obtained 
combined filtrates were applied on a C18 SD cartridge (4 mm, 1 ml). After the filtrate 
was applied on the SD catridge, the SD catridge was activated with Methanol. SD 
catridge was then washed with 80% acetonitrile and equilibrated to 0.1 M TEABC. 
The cartridge was washed two times with 200 µl 0.1 M TEABC and the desalted 
peptides were eluted with 100 µl 80% acetonitrile in 0.1 M TEABC. 
3.3.2.3 Isobaric tags for relative and absolute quantitation (iTRAQ) 
ITRAQ peptide labeling is performed based on the protocols by Effertz.C et al (68). 
15 µl of 1 M TEABC was added to the peptide sample prepared by FASP procedure, 
volume of which was reduced to 10 µl using centrifugal evaporator before adding 15 
µl of 1 M TEABC. Sample volumes were further adjusted to 30 µl with water. iTRAQ 
reagents 114 and 116 (AB Sciex) were dissolved in 70 µl ethanol and mixed with the 
corresponding samples immediately. Samples with iTRAQ reagents were incubated 
for 2 h at ambient temperature in the dark. After the incubation, the iTRAQ labeled 
samples were combined. The desalting of the samples was achieved using a C18 
SD cartridge as described above.  0.1 M TEABC was replaced by 0.1% formic acid 
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in all steps. Peptides labeled with iTRAQ from 3 different culture lysates were pooled 
for the further chromatographic peptide separation and MALDI analysis. 
3.3.2.4 Strong Cation Exchange HPLC 
Strong Cation Exchange (SCX) Chromatography was performed on an Ettan micro 
LC system (GE Healthcare) in split mode for iTRAQ labeled peptide fractionation 
before MALDI spotting. LC column with the dimentions of 0.5 mm x 150 mm was 
used. The column was packed with BioBasic SCX 5 µm (Thermo). The column was 
equilibrated in 25% acetonitrile in 0.1% formic acid. The sample flow rate of 20 
µl/min on the column was achieved with the combination of a “0.8 mm ID” restriction 
capillary (Dionex) and 125 µl/min pump flow. The samples were resuspended in 50 
µl of 40% acetonitrile containing 0.1% formic acid and were injected onto the column. 
Peptide separation was achieved by using a gradient of 0 M to 250 mM sodium 
chloride in 12 min. The fractions were collected every 60 sec. Acetonitrile from the 
samples was removed by subjecting the samples to brief vacuum centrifugation. 
0.1% TFA (Trifluoroacetic acid) was added to the samples to adjust the volume of 
the sample to 20 µl. 
3.3.2.5 MALDI Spotting 
MALDI spotting is perfomed according to the protocol mentioned by Effertz.C et al 
(68) and S. Staubach et al (69). Reversed phase HPLC on an Eksigent nano LC 1D 
plus system (Axel Semrau GmbH, Sprockhövel, Germany) is employed to separate 
the peptides obtained in the SCX fractions by using a vented column setup 
comprising a 0.1-mm/20-mm trapping column and a 0.075mm/200-mm analytical 
column (68). Both the trapping and analytical column were packed with ReproSil-Pur 
C18-AQ, 5 µm (Dr. Maisch, Ammerbuch, Germany) at 40°C. Sample fractions were 
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aspirated into the sample loop and were loaded onto the trap column with a volume 
of 18 µl and 30 µl respectively. Sample was loaded on trap column using a flow rate 
of 6 µl/min. 0.1 % TFA was used as loading pump buffer. Peptide elution from the 
column was performed over the period of 70 min with a flow rate of 300 nl/min.  
Peptide elution from the column was brought about by an eluting solution, which was 
a gradient of 5 % to 35% acetonitrile in 0.1% TFA. Post column T-union was injected 
with 0.7 mg/ml alpha-Cyano-4-hydroxycinnamic acid (HCCA) in 95% acetonitrile in 
0.1% TFA, 1 mM ammonium phosphate using a syringe pump. The rate of syringe 
pump injection was maintained at 150 µl/h. Probot (Dionex, Idstein, Germany) 
fraction collector was used to deposit 384 fractions (12 seconds) of elute on a MTB 
AnchorChip 384-800 MALDI target (Bruker Daltonics, Bremen, Germany). 
3.3.2.6 LC-MALDI MS/MS analysis 
MALDI MS and MS/MS analysis were carried out according to the protocols followed 
by Effertz.C et al (68), S. Staubach et al (69), S. Feldkirchner et al (70) on an 
Ultraflextreme MALDI Tof Tof mass spectrometer (Bruker Daltonics) operated with 
a laser repetition rate of 1 Ghz. MALDI MS spectra data were acquired with the help 
of Flexcontrol 3.0 and WarpLC. Spectra calibration was performed externally on the 
designated target calibration spots using the Peptide Calibration Standard II (all 
Bruker Daltonics). MS spectra data acquired peptide mass ranging from 700 Da – 
4000 Da. The laser was used with a fixed energy setting and 3000 shots/spectrum 
were collected from random raster points. Criteria for selecting precursor ions for 
MS/MS analysis was based on the signal to noise ration. Signal to noise ratio ≥10 
was used as a cut of for selecting precursor ion further MS/MS analysis. Identical 
peaks in adjacent spots were measured only once, preferentially from the spot with 
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maximum peak intensity. Each spot was restricted to maximum of 20 MS/MS 
spectra. With above mentioned restriction, if the alternative position is not witnessed, 
in that case the restriction is relaxed and the value of 20 MS/MS spectra per spot is 
exceeded. If the polymer signals and peaks appear on all spots atleast more than 
40%, those signals and peaks were filtered out. After the instrument calibration 
MS/MS spectra for 3500 shots were acquired.  Internal recalibration was performed 
by using iTRAQ reporter ions and peptide immonium ions. 
3.3.2.7 Database Searches 
Database search for MS/MS spectra acquired was carried out as mentioned by S. 
Feldkirchner et al (70) and was performed using University Hospital, Cologne 
internet source (uni-koeln.de). A composite decoy database was generated for 
MS/MS spectra acquired during LC-MS/MS experiment. Perl script makeDecoyDB 
(Bruker Daltonics, Bremen, Germany) was used to generate the composite decoy 
database from Uniprot database (August 10. 2010). The uniprot data composed of 
519348 sequences and 183273162 residues. To calculate the false positive rates, 
Perl script makeDecoyDB added a shuffled sequence and a tagged accession 
number for each entry is calculated in Proteinscape 2.1.The composit decoy 
database was further submitted to MASCOT 2.2 (Matrix Science Ltd, London, UK). 
MASCOT 2.2 via Proteinscape (Bruker Daltonics, Bremen, Germany) was used to 
search the decoy database. MASCOT 2.2 was employed with the parameter settings 
as listed below. 
MASCOT 2.2 parameter settings: 
1. Enzyme: “Trypsin” with 1 missed cleavage;
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2. Fixed modifications: “carbamidomethyl”, “iTRAQ4plex (K)”, “iTRAQ4plex (N-
term)” Optional modifications: “Methionine oxidation”, “iTRAQ4plex (Y)”, 
“Cation:Na (DE)”, “Acetyl (Protein N-term)” and “Gln>Pyro-Glu (N-Term Q)”. 
3. Mass tolerance: 20 ppm for MS and 1.0 Da for MS/MS spectra
4. Species filter:  “S. aureus”
Proteinscape was used to compile the protein list generated from MASCOT 2.2 
search engine. Ion score value > 25 was used as criteria to accept the peptide hits. 
Protein hits required at least one peptide hit exceeding a peptide score of 40. In 
addition, the hits to decoy entries were used to calculate a Minimal protein score, 
was calculated using the hits to decoy entries.  The false positive rate was kept <2% 
on the protein level. False positive rate <2% was achieved with the help of minimal 
protein score. 
Nano-LC MALDI experiments were perfomed at Center for Molecular Medicine 
Cologne, Germany with the help of Dr.Stephan Mueller. 
3.3.3 Gene expression analysis 
Two-hundred µl of an overnight culture of MSSA476 and CSB adapted MSSA strains 
with the OD of 6 were inoculated in 20 ml LB medium separately. The cultures were 
then incubated at 37°C for 4 hours. After 4 hours 0.5 mM of CSB was introduced to 
all the test tubes. Both the cultures were further incubated for another 30 min. The 
cultures were then harvested by centrifugation at an OD600 just above 3 (log 
phase).Both the bacterial pellets were washed at least 3 times with phosphate buffer. 
Both adapted and the non-adapted strains were resuspended in 150 µl of 100µg/ml 
lysostaphin and incubated for 10 min at 37°C. Suspensions were made up to 1 ml 
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with 30mM Tris HCL (pH 7.5). Suspensions were boiled at 100°C for 15 min.  After 
lyses, the samples were further used for RNA isolation. 
3.3.3.1 Isolation of RNA 
Quiagen universal tissue kit was used to isolate the RNA from the suspension. 
Protocol suggested by the manufacturer was used to isolate the RNA. An additional 
purification protocol was included to get rid of the genomic DNA contamination 
completely. The manufacturer’s protocol by RevertAid H Minus First Strand cDNA 
synthesis kit was followed to remove the genomic DNA from RNA preparation. (For 
1µg of RNA 1u RNase free DNase I was used.). 
3.3.3.2 c-DNA preparation 
Fifty ng of RNA from each sample was used to prepare cDNA. Reverse transcription 
reaction was performed using RevertAid H Minus First Strand cDNA Synthesis Kit 
and 30 µl of cDNA was prepared. The cDNA was further used to measure the 
relative quantities of m-RNA. 
3.3.3.3 Primers 
Using online primer designing software (BatchPrimer3 v1.0), primers were designed 
for the genes of interest. List of primer sequences for the respective genes is listed in 
Table 1. 
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Gene Primer Sequence (5′-3′) 
copZ copZ-F GAGCTGTGGTCACTGCAAAA 
copZ-B CGTCAGCTGAAGTGACACC 
agrA agrA-F TCACAGACTCATTGCCCATT 
agrA-B CACCGATGCATAGCAGTGTT 
clfA clfA- F AGCGAGCGATTCAGATTCAG 
clfA-B GTCGGAATCACTGTCGGAGT 
Spa spa- F GTTCGTCATGATGAGCGTGT 
spa – B TGAGGAGCCTCAACTTTTGG 
Table 1: List of forward (F) and reverse (B) primers used for the respective 
gene amplification. 
3.3.3.4 Real time PCR assay 
The mRNA levels of copper chaperon Z, clumping factor A, accessory gene 
regulatory protein A were quantified by using real time PCR assay using Sybgreen 
(Abi Prism 7000, Applied Biosystems). Housekeeping 16s rRNA gene product was 
also quantified and used to normalise the quantities of the other mRNAs. The Ct 
values were analysed, quality controlled and graphs of gene expression were plotted 
using the software qbase plus. The experiment was performed in both MSSA476 
and ErCu in triplicates. Gene expression analysis experiments were performed 
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under the supervision of Dr.E. Gomes, Institute for Legal Medicine, University 
Hospital, Cologne. 
3.4 Biofilm assay in MSSA476 and ErCu strain 
The microtiter dish biofilm assay is performed using static growth conditions, 
therefore the mature biofilm formation can be avoided and the early stages in 
bacterial biofilm formation can be studied (71). 
Overnight cultures of MSSA476 and ErCu with the same OD of 5 were 1:100 diluted 
in LB medium.100 μl of each diluted culture was transferred into each well in a fresh 
tissue culture untreated 24 well microtiter plate. Microtitre plate was covered with the 
lid and incubated at 37°C over night. Planktonic bacteria from each microtiter dish 
were removed by briskly shaking the dish out in a waste tray. Wells were further 
washed by submerging the plate in the tray with 1-2 inches of water. Thus, filled 
water was removed in the wash tray by vigorously shaking out the liquid. Water was 
replaced when it became cloudy. 125 μl of 0.1% crystal violet solution is added to 
each well. Micro titer plate was incubated for 10 min at room temperature. Each 
micro titer dish was shaken and crystal violet solution is removed over the waste 
tray. Dishes were further washed again 2 more times in the water trays and as much 
liquid as possible is removed from the dish after each wash. Micro titer dish was 
inverted and vigorously tapped on paper towels to remove any excess liquid. Plates 
are air-dried. 200 μl of 95% ethanol is added to each stained well. Dye is allowed to 
solubilize by covering plates and incubating 10 to 15 min at room temperature. The 
contents of each well were mixed by pipetting, and then 125 μl of the crystal 
violet/ethanol solution from each well is transferred to a separate new clear flat-
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bottom 96-well plate. Optical density (OD) of the samples was measured at a 
wavelength of 600 nm. 
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4. Results
4.1 Evolution of CSB resistance in MSSA476 
Figure 3: Growth of CSB sensitive MSSA476 and CSB tolerant ErCu strain A) 
No growth was observed in CSB tolerant MSSA476 incubated in LB with 
0.8mM CSB at 37 °C for 18h B) Growth observed in CSB adapted ErCu strain 
incubated in LB with 0.8mM CSB at 37 °C for 18 h 
Non passaged wild type MSSA476 showed no significant growth when incubated in 
LB media with 0.8mM CSB at 37°C for 18 h as shown by clear green solution in Fig. 
3A, whereas CSB passaged MSSA476 showed after the mircoevolution 
expermiment significant growth when incubated in LB media with 0.8mM CSB at 
37°C for 18 h represented by the turbid solution in Fig. 3B. 
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Bacterial growth was determined by measuring Optical Density (OD) of the cultures 
at 600nm wavelength at various concentrations of CSB. 
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Figure 4: Graphical representation of CSB tolerance of sensitive and tolerant 
strains. Optical density at 600 nm after 18 h of incubation of non-adapted (grey 
circles) and adapted MSSA476 (ErCu) (black squares) at different 
concentration of CSB in LB medium. Samples were diluted 1:10 before the 
readings were taken (n=3). 
After the microevolution, experiments the tolerance against CSB was compared 
between the CSB adapted ErCu and its non-CSB adapted ancestral strain MSSA 
476. Fig. 4 shows the optical densities at different CSB concentrations after 18 h. As 
depicted both the cultures grow in a medium lacking CSB to an OD of about 5 to 5.5 
(Fig. 4). With increasing CSB concentration up to 0.4 mM, the OD of both the 
cultures increases slightly to about 6. At a concentration of 0.6 mM of CSB, a 
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marked difference in copper tolerance was observed. At 0.8 mM, nearly no growth 
could be determined for the MSSA476. In contrast to that, the CSB adapted ErCu 
was still able to grow to an OD600 of 5 at 0.8 mM of CSB concentration. 
As shown in the Fig. 3 and 4, ErCu strain is able to grow better than, wildtype 
MSSA476 at 0.6 mM and up to 0.8 mM of CSB. 
4.1.1 Confirmation of microevolved S.aureus strain 
Figure 4.1: Agarose gel electrophoresis showing 270bp fragment of nuc gene 
in MSSA476, ErCu (Lane 2 and 3), and in S.carnosus as the negative controll 
(Lane 4), 1Kbp ladder (Lane 1). Picture has been edited to remove the non-
relevant lanes. Non edited figure can be refered in appendix (7.5) 
Fig. 4.1 shows amplified nuc gene fragment band in MSSA476 (positive control) and 
Ercu strains. No nuc gene band can be seen for S.carnosus (negative control) as 
expected. 
1 2 3 4 
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Figure 4.2: Cultures grown in mannitol agar media. A) MSSA476 culture B) 
ErCu cultures 
Fig. 4.2 shows growth of yellow MSSA476 (positive control) and ErCu colonies in 
mannitol agar medium which is used to pick the non-contaminated S.aureus 
colonies. 
A B 
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 4.2 Characterisation of ErCu strain 
4.2.1 Intracellular superoxide anion measurement 
Figure 5: Intracellular superoxide anion measurement in ErCu and MSSA476 
strains grown in the presence of 0.5 mM CSB. Flourescence reading of EB can 
be refered in appendix 7.1 
Fig. 5 shows the fluorescence of EB originating from the relative amounts of 
superoxide in MSSA476 and ErCu, it can be seen that the production of EB is 
considerably higher in case of MSSA476 than ErCu. This suggests that, there is a 
higher superoxide anion production in MSSA476 than in ErCu. 
Superoxide dismutase is a marker of oxidative stress created by toxic reactive 
oxygen species (ROS) like superoxide anion (61) (62). Therefore, the generation of 
superoxide was measured. Decreased superoxide anion in ErCu is a clear indication 
of reduced Superoxide dismutase in ErCu, which was further, confirmed in 
comparative proteomics experiment as well (Table 3). Reduced Superoxide 
dismutase indicates lower oxidative stress in ErCu. 
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4.2.2 Cellular copper concentration measurement 
Insights in to the copper hemostasis mechanism in ErCu are possible by comparing 
the cellular copper concentration of Ercu with MSSA476.  
Figure 6: Concentration of copper ions measured by ICP-MS present in the 
MSSA476 and ErCu cells grown in 0.5mM CSB. Measurement is expressed in 
mg/L of sample processed. Error bars indicate the deviation of 3 independent 
experiments. ICP-MS reading and standard deviation calculated can be refered 
in appendix 7.2 
The copper concentration for the ErCu strain is at an average of 8.37 mg/L of lysate, 
where as MSSA476, showed an average concentration of 9.5 mg/L of lysate. 
Student’s T test was performed to validate the data. T test gave the value of 0.041, 
which can be taken as a proof that the experimental data are statistically significant. 
From the observations, it is clear that ErCu is able to maintain cellular copper 
homeostasis better than MSSA476. The molecular mechanism of copper 
homeostasis in case of ErCu is further determined by comparative proteomics 
experiments (Chapter, 4.3.2). 
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4.2.3 Phenotypic expression of virulence factors. 
It is well recorded that under heavy metal stress, virulence of S.aureus is diminished 
(72, 73). To understand the virulence ability of ErCu and MSSA476, slide coagulase 
test, blood agar test and Caenorhabditis elegans (C.elegan) growth assay were 
performed. Slide coagulase test helps detecting virulence factors like clumping factor 
in bacteria, whereas blood agar test determines the hemolytic activity of bacteria. 
Virulence bio-assay is based on the larval development of C.elegans. 
Coagulase test (clumping factor test) showed a microscopic clumping within 30 sec. 
in MSSA476 (positive control). In contrast, the ErCu did not show such an effect, nor 
did S. carnosus, which was used as negative control. 
Figure 7: Hemolytic test on blood agar. A: ErCu on LB Agar containing human 
blood. B: MSSA476 on LB Agar containing human blood, white arrow indicates 
the hemolytic zone 
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In hemolytic test, when MSSA476 culture (positive control) is compared to the ErCu 
strain on the same blood agar plate (Fig. 7), a significant hemolytic zone can be 
seen around the MSSA476 culture (Fig. 7 B) as compared to the ErCu strain (Fig. 7 
A). This indicates the release of toxins causing hemolysis in case of MSSA476 strain 
only. In conclusion ErCu does not show hemolytic activity and no bound coagulase 
activity (clumping factor). These indications for reduced virulence in ErCu were 
confirmed In C.elegan growth assay. 
The number of living L4 nematode stages are shown after incubation together with 
MSSA476 or ErCu or E. coli op 50, respectively (Fig. 8). 
Figure 8: C. elegan growth assay to test the virulence of ErCu and MSSA476 
strains: In the presence of virulent MSSA476 (positive control) only a few 
viable L4 staged nematodes were detected after 48 h of incubation. In contrast, 
in cultures with ErCu strain a large number of L4 staged nematodes were 
detected. The same is found for E. coli op 50 (negative control). n=3 
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As shown in the graph in Fig. 8, far more living individuals of C. elegans in L4 stage 
were detected which were grown on CSB adapted ErCu strain in comparison to the 
C. elegans grown on the wild type strain. The highest number of C. elegans (on 
average 19 nematodes) in L4 stage was counted after feeding on E. coli op 50 
(negative control). 
Comparative proteomics experiments were performed to obtain further insights in to 
this phenomenon. 
4.3 Comparative Studies between MSSA476 and ErCu strain with respect to 
protein and gene expression 
For the comparison of the complete proteome of MSSA476 and ErCu strain, 2D- 
Differential In Gel Electrophoresis (2D-DIGE) and nano Liquid Chromatography –
Matrix Associated Laser Desorption Ionisation (nano LC-MALDI) with isobaric tags 
for relative and absolute quantitation (iTRAQ) were used. Differential labelling of N-
terminus of the peptides by isobaric tags is the principle behind nano LC-MALDI 
technique. Tagged samples are further analysed by tandem mass spectrometry for 
the relative quantitation (58).  
4.3.1 Two- Dimentional Differential In Gel Electrophoresis (2D-DIGE) analysis 
2D-gel electrophoresis is a technique used to resolve individual proteins from a 
complex protein cocktail. The resolution of proteins is based on their respective 
isoelectric points and molecular weights. The proteins observed in this study are 
limited to the iso electric points ranging from pH 4-7. Therefore, extremely acidic or 
basic proteins could not be resolved. 
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Figure 9A: Protein pattern of A) ErCu and B) MSSA476 parent strains grown in 
0.5mM CSB obtained by 2D-DIGE. 5 down regulated protein spots are marked 
and numbered in the ErCu gel. 
With 2D-DIGE analysis, over 2000 protein spots were found on the gel. Student’s t 
test was performed to validate the statistical significance of obtained data. On the out 
set several hundred proteins seem to be differentially expressed in ErCu. However, 
up on analysis by ‘Decyder’ image analysis software andStudent’s t test only 6 
proteins were reavealed to be statistically verified differentially expressed in ErCu 
(five down-regulated and one up-regulated). Out of six, five proteins were revealed to 
be down-regulated in ErCu with the Student’s t test score under 0.01 (Proteins with 
student’s t test score ≤0.01 are generally considered statistically significant in case of 
2D-DIGE experiments globally). Five down regulated proteins, with their expression 
levels as compared to MSSA476, statistical analysis scores and functions are listed 
in table 2. 
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Table 2: List of down regulated proteins in ErCu, with their expression levels 
as compared to MSSA476, statistical analysis scores and functions. Functions 
of the proteins listed were referred from uniport (www.uniprot.org) 
Protein name T-test Protein 
expression 
Functions 
1 Aspartyl/glutamyl‐tRNA  
amidotransferase subunit A 
0.0039 -1.62 Purine 
biosynthesis 
2 Aldehyde dehydrogenase 
like protein 
0.0039 -1.71 Production of 
ATP and 
maintain energy 
pool 
3 Inositol monophosphate 
dehydrogenase 
0.0039 -1.91 Maintaining the 
guanine 
nucleotide pool 
4 Fumarate hydratase 0.0039 -1.56 Production of 
ATP and 
maintain energy 
pool 
5 Ornithine‐oxo‐acid 
transaminase 
0.0066 -1.98 L-proline 
biosynthesis 
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Spectrometry data MASCOT search results and screen shot for Student’s t test 
analysed by ‘DeCyder’ software for above mentioned proteins can be refered in 
appendix (7.6, 7.7). 
According to www.uniprot.org, the functions of the 5 down regulated proteins 
mentioned in the table 2 indicate, the involvement of the proteins in bacterial 
metabolism and metabolic energy pool. However, the role of down-regulated 
proteins in the adaptation mechanism is unclear. Further investigation is required to 
determine whether the down–regulation of above listed proteins is a random event or 
they play a role in CSB tolerance in ErCu. 
2D-DIGE analysis also revealed one up-regulated protein in ErCu (Fig. 9B) which is 
statistically significant based on student’s t test. 
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A) ErCu B) MSSA 476
Figure 9B: Protein pattern of A) ErCu and B) MSSA476 grown in 0.5mM CSB 
obtained by 2D-DIGE showing SpoVG spot. 
A) ErCu B) MSSA 476
Figure 10: 3D view representation of 2D-DIGE expression of SpoVG in case of 
A) ErCu as in relation to the B) MSSA476 strain.
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Figure 11: Mass spectrometry data MASCOT search results for SpoVG protein.  
Number of hits suggests number peptide hits, which could have a similar peptide 
sequence. However, the hits obtained could be the result of random events due to 
false positives and other background sequences. Probability based mowse 
(Molecular Weight SEarch) score is -10*Log (P), where P is the probability that the 
observed match is a random event. Mowse scores > 67 indicate identity or extensive 
homology (p<0.05). Protein scores are derived from ions scores as a non-
probabilistic basis for ranking protein hits. Scores in the green shaded region are not 
significant (at a level of p= 5%). 
In Fig. 11, putative septation protein SpoVG scores the highest Mowse score of 460, 
which is much higher than the cut off score of 67. The higher the mowse score, the 
lower is the probability that the identified protein is a random event. Therefore, 
identified protein can be confirmed as SpoVG with the highest score of 460. 
2D-DIGE analysis shows 1.90 times increase in the Putative septation protein 
SpoVG (protein ID: Q5HIH8 /SP5G_STAAC) in ErCu as compared to MSSA476. 
Student’s t test analysis was performed to validate the statistical significance of the 
data obtained. Student’s t test analysis gave the value of 0.011, which can be 
considered as proof that the experimental data obtained are statistically significant. 
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Only 2 times increase in SpoVG expression itself is generally not considered enough 
to make all the differences seen in ErCu and MSSA476. However, increase in the 
expression is consistent in 4 different ErCu cultures, indicating its role in CSB 
tolerance in ErCu. Further comparative studies were performed to identify other 
factors involved in the tolerance against CSB. The role of down-regulated proteins in 
the adaptation mechanism is unclear. Further investigation is required to determine 
whether the down–regulation of above listed proteins is a random event or they play 
a role in CSB tolerance in ErCu. 
4.3.2 Nano LC- MALDI mass spectrometry analysis 
Protein resolution with nano LC-MALDI is based on the principle of differential 
labelling of N-terminus of the peptides by isobaric tags. Tagged samples are further 
analysed by tandem mass spectrometry for the relative quantitation (58). 
After 2D-DIGE proteome analysis, nano-LC MALDI technique was employed for 
further proteome analysis based on the advantages of nano-LC MALDI over 2D-
DIGE (Chapter 1). 
Using nano LC-MALDI mass spectrometry, we could analyse 457 proteins 
quantitatively (supplement). We were able to compare the expression of these 
proteins between ErCu and MSSA476. Out of 457 proteins, 23 proteins were found 
to be up regulated more than 1.5 times in ErCu. 56 proteins in ErCu were found to 
have the expression levels below 70% as compared to the ancestral MSSA476 
strain. In table 3, some of the proteins and their expressions in relation to the 
MSSA476 strain and their functions are listed which appear to be relevant with 
respect to heavy metal stress, oxidative stress, virulence and biofilm formation. 
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Protein /ID Protein ID 
(Uniprot) 
Gene 
symbol 
Protein 
expression (in 
relation to the 
ancestral strain) 
Functions 
Copper 
chaperon Z 
Q6GDP0/
COPZ_ST
AAR 
Copz Expressed at 38% 
level 
CopZ chaperon plays an 
important role in the 
export of copper across 
the cell membrane. 
(74). 
Superoxide 
dismutase 
Q2YUU9/
SODM2_
STAAB 
SODM2 Expressed at 69% 
level 
Superoxide dismutase is 
a marker of oxidative 
stress, which helps the 
cells to cope up with toxic 
reactive oxygen species 
(ROS) like superoxide 
anion (61) (62) 
Immunoglobu
lin G-binding 
protein A 
P02976|S
PA_STAA
8 
Spa expressed at 14% 
level 
Surface Protein present 
in the cell wall of the 
bacteria S. aureus. It 
helps to inhibit 
phagocytosis, S. aureus 
lacking this protein show 
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a diminished virulence. 
Accessory 
gene 
regulatory 
protein A 
Q5HEG2/
AGRA_ST
AAC 
agrA expressed at 57% 
level 
Accessory gene 
regulatory protein A is an 
important regulator of 
virulence factors of S. 
aureus. 
Clumping 
factor A 
Q6GB45 
/CLFA_ST
AAS 
clfA expressed at 12% 
level 
Activates platelets 
aggregation, Helps the 
bacteria to attach to the 
fibrinogen hence forming 
bacterial clumps. 
Convincingly associated 
with pathogenicity of 
S.aureus   
Table 3: Protein expression revealed in nano LC-MALDI; Proteins with 
decreased expression, in case of evolutionarily CSB adapted MSSA476 (ErCu) 
in relation to the MSSA476 strain which appear to be relevant with respect to 
heavy metal stress, oxidative stress, virulence and biofilm formation. Protein 
functions were referred from the data base uniprot. (www.uniprot.com). 
Nano LC-MALDI analysis showed a significant decrease in copper chaperone copZ 
and superoxide dismutase (SODM2) expression. It can also be noticed that 
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expression of virulence factors immunoglobulin G-binding protein A (spa), accessory 
gene regulatory protein A (agrA) and clumping factor A (clfA), are also reduced to a 
great extent. (See table 3). 
Nano LC-MALDI data of agrA, clfA, spA, and copZ were further confirmed by gene 
expression analysis as well. Increased level of SODM2 in MSSA476 than that of 
ErCu found in nano LC-MALDI data was already indicated by the superoxide anion 
measurement experiments (Fig. 5). 
Analysis with nano LC-MALDI mass spectrometry revealed a decrease in the protein 
Copper chaperone CopZ (expressed only at 38% level) in ErCu strains. CopZ 
chaperon is responsible for the intracellular sequestration of Cu+
(74)(www.uniprot.org). The corresponding gene copZ forms an important component 
of copAZ operon and plays an important role in homeostasis of copper in the cell 
(74).
In previously performed slide coagulase test, blood agar test and C.elegan growth 
analysis, reduced virulence in ErCu was observed (Fig. 7, 8 and 12). Complimentary 
to the virulence analysis results, nano LC-MALDI proteomics was also able to 
identify some of the virulence factors, which were affected by the adaptation. 
Accessory gene regulatory protein A (agrA) is a component of accessory gene 
regulatory system (agr) which is shown to be reduced in ErCu. Agr system plays an 
important role in the virulence of S. aureus (75). Reduced virulence factors like 
clumping factor A (clfA) and reduced agrA protein indicates reduced virulence in 
ErCu cells. 
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4.3.3 Gene expression analysis 
Nano LC-MALDI experiment was performed on protein samples, which were pooled 
together from 3 different cultures. However, the experiment was run only once as an 
identification step. Because of the preliminary and therefore only indicative character 
of the nano LC-MALDI experiments (see chapter 3.3.2), statistical analysis cannot be 
applied to confirm the data. To confirm the nano LC-MALDI data, gene expression 
analysis as complementary experiments was carried out on selected proteins from 
nano LC-MALDI data, which appear to be relevant to our study. 
Figure 12: Expressions (arbitrary unit) of the genes agrA, clfA, copZ, spa  in 
case of MSSA476 (oblique line filling) and ErCu (solid bars). Graph was 
generated with the software ‘qbase plus’, by Dr.Eva Gomez at the Institute of 
Legal Medicine, University Hospital Cologne, Germany. Cq value readings 
from real time RT-PCR can be refered in appendinx 7.3 
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Fig. 12 shows the relative expression of the genes agrA, clfA, copZ and spa in 
relation to each other. Gene expression of copper chaperon Z (copZ), clumping 
factor A (clfA), accessory gene regulatory protein A (agrA) were reduced respectively 
in case of ErCu strain as compared to the expression in MSSA476. In case of ErCu 
strain Immunoglobulin G binding protein A (spa) gene showed decreased 
expression, but  we observed high quantifictioncycle  values (Cq values) for the spa 
gene. Student’s t-test p value for spa gene did not fall in the significance range 
(p≤0.05). This suggests that the differences in gene expression were not sufficient 
for the detection. However, it is possibility that the gene expression signals may not 
fall in the limit of detection of the RT-PCR.  The high Cq values which are  out of limit 
signal for the detection of RT-PCR were excluded as the same RNA and 
amplification conditions were also used for the other target genes analysed. 
However, expression of spa protein is shown to be down regulated in nano LC-
MALDI experiments. 
With a shadow of doubt on spa gene expression, the remaining determined gene 
expressions are in good accordance with the proteomics results mentioned above 
(nano LC- MALDI). Therefore, nano LC-MALDI data can be confirmed and used for 
further analysis. SODM2, which is highlighted in nano LC-MALDI data, is already 
confirmed in the intracellular superoxide anion measurement experiment (Fig. 5). 
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4.4 Biofilm assay 
This experiment was designed to confirm increase in biofilm formation due to 
increase in SpoVG protein in ErCu as suggested by 2D-DIGE analysis. 
Figure 13: Biofilm assay: Optical density measurement of ErCu and MSSA476 
strains stained with crystal violet (0.1%). OD values for crystal violet intensity 
with the standard deviations can be refered in appendix 7.4  
Fig. 13 shows higher OD measurement of 0.1% crystal violet at 600nm in case of 
ErCu as compared to MSSA476 strain. Higher OD values of 0.1% crystal violet 
staining of ErCu proves that ErCu has the higher ability of forming biofilm as 
compared to MSSA476 strain. 
The earlier stages of biofilm due to static growth conditions were measured by 
crystal violet stain. Early stage biofilm formation assay appropriately fitted our study, 
as bacterial growth conditions used in proteomics study were at the exponential 
growth phase. . 
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5. Discussion
5.1 Evolutionary tolerance of ErCu strain against CSB 
When a constant pressure is created by heavy metals like copper in the bacterial 
environment, it leads to selection of new variant bacterial strains, which are resistant 
to the heavy metals (56, 57). Comparative studies between micro evolved S. aureus 
(ErCu) against copper and the wild type S.aureus (MSSA476) at the molecular level 
will provide insights in to the mechanism by which S. aureus evolves and adapts to 
the pressure created by the copper complexes. Therefore, experiments were 
designed of microevolution of MSSA476 in order to obtain resistance against copper-
Schiff’s base (CSB). 
As depicted in Fig. 3 and 4 ErCu is clearly more tolerant to CSB than MSSA476 
strain. Minimal Inhibitory concentration (MIC) experiments conducted by N. Poulter 
et al. on CSB against MSSA476 strain exhibited MIC100 at 0.5 mM (1). In this study, 
MIC100 for CSB against MSSA476 was found to be close to 0.8 mM. Along with the 
experimental conditions and the laboratory conditions, the difference in MIC100 could 
be due to the different concentration of DMSO used in the preparation of CSB 
solution. Eventhough, our preliminary experiments (results not shown) did not show 
any significant anti-microbial activity for 1% DMSO. Anti-microbial activity of higher 
concentration of DMSO needs to be investigated. Therefore, 2% DMSO used by N. 
Poulter et al. could be one of the reasons for lower MIC100 as compared to the 
MIC100 achived by using 1% DMSO in this study. 
To confirm whether microevolved S.aureus is essentially still S.aureus and to rule 
out the possibility of selection of false bacteria during microevolution, PCR and 
mannitol agar tests were performed. 
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PCR tests were run to confirm presence of nuc gene in ErCu. Nuc gene is a 270 bp 
DNA fragment which codes for thermo stable nuclease in S.aureus which is highly 
conserved (60). Hence , it is a good candidate which can be used to detect S.aureus 
(60). Mannitol is a fermentable carbohydrate. And S.aureus is the only bacterium 
which is known to ferment mannitol. Phenol red a pH indicator present in mannitol 
agar media indicates the change in the pH of the media. Due to fermentation of 
mannitol salt S.aureus colonies appear yellow in colour with yellow zones 
surrounding the colonies (76). 
Presence of nuc gene band in PCR experiments (Fig 4.1) and the mannitol agar 
tests clearly confirm that microeveloved ErCu is still essentially an S.aureus strain. 
Picking a single yellow ErCu colony from mannitol agar media for further culturing 
and storage assures non-contaminated cultures for further experiments. 
Microevolution experiment results indicate that due to the constant pressure created 
by copper in the bacterial environment, adapted MSSA476 attained better fitness to 
copper stress environmentwhich shows amore tolerance to higher concentrations of 
copper. 
Stress by heavy metals is often directly related to oxidative stress in S. aureus. (77-
80). If ErCu strain has indeed developed an adaptation to CSB, then it should also 
be able to cope better with oxidative stress. Superoxide dismutase (SODM2), which 
is a marker of oxidative stress, catalyses detoxification of superoxide anion to H2O2 
which is further broken down to H2O by the enzyme catalase (61, 62). Nano LC- 
MALDI results, show decreased level of SODM2 in ErCu cells. This suggests that 
ErCu strain experiences  reduced oxidative stress as compared to MSSA476 strain 
when exposed to super-physiological concentrations of copper or CSB. To confirm 
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this result, concentration of superoxide anion present within the cell was also 
measured. The results are in agreement with the proteomics results. (Fig. 5). A lower 
amount of copper ions present in ErCu cells as in non-adapted MSSA 476 cells was 
confirmed by ICP-MS experiments (Fig. 6). This suggests that less copper ion are 
entering the cells and therefore the ROS cascade usually triggered by super-
physiological copper concentrations is not activated as observed in case of the 
nonadapted MSSA 476. 
5.2 Factors involved in the tolerance of CSB in ErCu strain 
When there is an increase in the cellular copper level above physiological levels, 
bacteria activates the mechanism of copper homeostasis in the cell perhaps by 
activating copAZ operon (74). Analysis with nano LC-MALDI mass spectrometry 
revealed a decrease in the protein Copper chaperone CopZ (expressed only at 30% 
level) in ErCu strains as compared to MSSA476 strain. This result was further 
confirmed by using real time reverse transcription (RT) -PCR (12). CopZ chaperon is 
responsible for the intracellular sequestration of Cu+ and the corresponding gene 
copZ forms an important component of copAZ operon. When there is an increase in 
cellular copper above physiological levels, copZ is activated leading to a cascade 
that activates copB, which removes copper from the cell, hence maintaining the 
copper homeostasis in the cell (74). 
According to our ICP-MS experiments (Fig. 6), it is evident that the copper levels 
were found to be lower in ErCu cells than in the MSSA476 cells. Reduced copper 
concentration in ErCu cells suggests that either the export of copper is more efficient 
or entrance of the copper is inhibited in the ErCu cells. As shown in the results, 
reduced expression of copZ in the ErCu cells strongly suggests that the adapted 
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bacterial strain has developed mechanisms, which does not improve export but block 
the entry of excess copper ions in to the bacterial cells. Together with the results on 
oxidative stress, this becomes even more evident. 
5.3 Increased Biofilm formation in ErCu 
Biofilm
formation
SpoVG
Tolerance towards 
heavy metal stress, 
oxidative stress, 
antibiotics
AgrA
Agr system
Agr related virulence 
factors
Figure 14: Schematic representation of molecular adaptation by ErCu, which 
will lead to enhanced biofilm formation. Dotted lines represent repression and 
solid lines represent elevated expression. 
It has been demonstrated that the repression of regulatory protein SpoVG also 
represses biofilm formation in S.aureus (39).  
In 2D-DIGE comparative proteome analysis, approximately 2 times increase in 
SpoVG protein is observed in ErCu strain (Fig. 9B and 10), which indicates increase 
in the biofilm formation in ErCu. The microtiter dish biofilm assay is performed to 
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analyse biofilm formation in ErCu and MSSA476. Biofilm assay is performed using 
static growth conditions, therefore the mature biofilm formation can be avoided and 
the early stages in bacterial biofilm formation can be studied (71). The biofilm assay 
confirms increased biofilm formation in ErCu (Fig. 13). 
 Moreover, while characterizing the ErCu strain, hemolytic tests indicated reduced 
release of toxins. Moreover, nano LC-MALDI and gene expression results also 
showed down regulation of clfA and spa in ErCu (Table 3, Fig.12). The clumping  
factor formation by S. aureus is convincingly related to the virulence of  S. aureus  
(81). Therefore, hemolytic test results and reduced clfA protein indicates global 
reduction of virulence in ErCu. To confirm reduced virulence, a growth test was 
conducted on C.elegans. C. elegans were chosen because there is a remarkably 
high degree of correlation between pathogen virulence factor required for nematode 
killing and virulence in vertebrate models (82). Quicker growth of C. elegans from L1 
to L4 stage in case of ErCu infected C. elegans as compared to the C. elegans 
infected by MSSA476 strain confirms the reduced virulence of ErCu strain. 
Therefore, increased copper tolerance, enhanced biofilm formation and reduced 
virulence appear to coincide in ErCu. A possible unifying concept for these 
observations may be the following hypothesis: 
It has been established that increased biofilm formation leads to enhanced oxidative 
stress tolerance in bacteria (30-32). Contrary to opportunistic pathogens like 
Pseudomonas aeruginosa, the repression of quorum sensing system is necessary to 
form a biofilm in case of S. aureus, and when there is a reactivation of quorum 
sensing in the biofilms, dispersion of the cells can be witnessed(33) (83-85). It is 
established that in S.aureus, the quorum-sensing system is regulated by agr system 
and a communication molecule called auto inducing peptide (AIP)(86). Blaise R. 
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Boles, and Alexander R. Horswill have demonstrated that repression of agr is 
necessary to form a biofilm (33-38) which co-relates to our nano LC- MALDI and real 
time reverse transcription (RT)-PCR results (Fig. 12). With nano LC-MALDI and RT-
PCR experiments we were able to show that accessory gene regulatory protein A 
(agrA), a component of accessory gene regulatory system (agr) (87) is reduced in 
Ercu (Table 3 and Fig. 12). AgrA modulates agr system by activating RNAIII, an 
effector molecule of agr (87-90). Therefore, reduced agrA indicates repression of agr 
system. And repression of agr also means reduced virulence as explained above 
(75) (Fig. 7,8 and 12). Even though previous studies showed that clumping factor A 
(clfA) expression, a surface virulence protein (81),  s independent of agr activity (91, 
92), nano LC-MALDI and gene expression results of this study demonstrated down 
regulation of clfA in ErCu (Table 3 and Fig. 12). when the stress is applied on 
S.aureus, stress resistant S. aureus survives because of it’s fitness advantage at the 
cost of global reduction of virulence factors (23, 26-28). Therefore, reduced 
expression of virulence factors like clfA and spa can be attributed to the global 
reduction of virulence factors, which also include the virulence factors that are not 
regulated by agr system in stress adapted ErCu strain. However, in depth 
investigation of clfA protein in ErCu is required. 
The major observation is that increase in SpoVG and decrease in agr system both 
explain biofilm formation, which in turn ‘leads to increased copper tolerance. 
Resistance against antibiotics like ciprofloxacin, mupirocin, and rifampin is seen in 
agr deficient S.aureus (17, 23). Agr deficient S.aureus have also exhibited 
intermediatery level resistance against glycopeptides like vancomycin (17). And 
because of the deficient Agr system reduced extracellular virulence factors have 
been noticed in antibiotic resistant S.aureus strains (23, 93-95). The factors 
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observed in antibiotic resistance in S.aureus are smiliar to the observations made in 
the resistnace mechanism of S.aureus against CSB in this study. In addition, 
increase in the cell wall thickness in vancomycin resistant S.aureus (10-12) indicates 
increase in SpoVG. An increase of SpoVG was also observed in ErCu strain. The 
uncanny similarities in the mechanisms of antibiotic resistance and CSB resistance 
in S.aureus suggests cross resistnace for antibiotic and CSB stress on S.aureus. 
Further investigations are required to examine whether ErCu strain also exhibits 
resistance against a range of antibiotics like ciprofloxacin, mupirocin, rifampin and 
vancomycin. However, preliminary experiments were conducted to determine 
whether ErCu has developed a capsule or a thicker cell wall as compared to 
MSSA476 using India ink staining technique. Eventhough results were only 
preliminary and not confirmatory, no considerable difference was observed between 
MSSA476 and ErCu (results not shown). 
Therefore, along with the biofilm mediated resistance theory, cell wall thickening for 
resistance needs to be further investigated in ErCu. 
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5.4. Interrelation of agr system and SpoVG in S.aureus 
Sigma B  yabJ  SpoVG
j,RNAIII Agr
system
EsxA
virulence 
factor
Antagonizing role of spoVG SpoVG
Figure 15: Schematic representation of interrelation of SpoVG and agr system 
as suggested by Schulthess, et al. (2011, 2012) 
As discussed above, both increased SpoVG and repression of agr are effectors of 
biofilm formation. One explanation is that SpoVG has a negative effective on agr 
system, which facilitates biofilm formation. SpoVG as a part of yabJ-spoVG 
regulatory system it is positively modulated by sigmaB and infact yabJ-spoVG locus 
may serve as effector that modulates sigmaB effects over sigmaB-dependent genes 
(16). SigmaB on the other hand is known to have a repressing effect on agr system 
(38, 79, 96, 97). Hence, it could be assumed that sigmaB is the common factor, 
which is responsible for up-regulation of SpoVG and down regulation of agr system 
seen in ErCu. However, expression of alkaline shock protein (asp23) marker of 
sigmaB in S.aureus (98-100) seems to be reduced in ErCu according to nano LC-
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MALDI data (see appendix 7.8). Nano LC-MALDI analysis can be used as an 
identification step; hence, this puzzling result needs to be confirmed with another 
method like gene expression analysis. Asp23 expression revealed by nano LC-
MALDI is not confirmed by gene expression data. Therefore, asp23 expression data 
from nano LC-MALDI is not considered conclusively. Hence, in the absence of 
second independent result, it cannot be concluded whether SigmaB activity is 
actually increased in ErCu. Nonetheless up regulation of SpoVG and down 
regulation of agr system are confirmed beyond doubt with the help of 2D-DIGE, nano 
LC-MALDI and gene expression analysis. If there is infact reduced sigmaB activity in 
ErCu, further investigations are required to understand the mechanism of how 
SpoVG is able to bypass the effect of sigmaB in ErCu. Schulthess et al (2012) 
demonstrated that depending upon the growth conditions and other environmental 
factors SpoVG takes an opposing role to sigmaB in regulation of virulence factor 
esxA protein in S.aureus. This demonstrates the ability of SpoVG to antagonize the 
effect of sigmB on virulence factor like esxA and agr system (101, 102). It can be 
proposed that even if sigmaB activity is indeed reduced in Ercu, SpoVG is able to 
modulate the effect of sigmaB on its own expression and on agr expression. Hence, 
it can be concluded that irrespective of sigmaB expression, increase in SpoVG 
mediates repression of agr system. 
5.5 Biofilm formation and its role in heavy metal stress tolerance in ErCu 
It can be proposed that, at the time when bacterial cultures are harvested (in the 
exponential growth phase) for the experiments, ErCu cells are more advanced in 
biofilm formation than control cells due to increased expression of SpoVG and 
repression of the agr system. Because of the reduced agr system, we also observe 
reduced virulence in ErCu strain. To conclude the mechanism of CSB adaptation in 
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S.aureus, it can be suggested that ErCu has developed a mechanism, which 
enables the bacteria to form biofilm at an earlier stage with the help of increased 
SpoVG and decreased agr activity. Improved formation of biofilm coincides with 
adaptation of S.aureus against high concentrations of Cu ions. Staphylococcal 
biofilms are composed of N-acetyl-glucosamine-based exoploysaccharides, also 
known as polysaccharide intercellular adhesin (PIA), cytoplasmic proteins and 
polyanionic extracellular DNA (103, 104). It is well known that biofilms cause 
dramatically increased resistance to antibiotics. Evidence also suggests that biofilms 
protect from toxic metals by the combined action of physical and chemical 
interactions. The extracellular matrix not only impedes the diffusion of small 
molecules but, in addition, immobilizes toxic metals, for example by ionic interaction 
of opposite charges (DNA), precipitation and biosorption (105) (106). 
As a whole range of factors is involved in the complex process of biofilm formation, it 
is difficult to pinpoint specific mutations, which cause the phenotype of the CSB 
tolerant phenotype of strain ErCu. The consequences of enhanced biofilm formation 
on stress tolerance are, nonetheless, dramatic and likely to affect a multitude of 
antimicrobials, including heavy metals and antibiotics. We have shown here that 
exposure to inhibitory concentrations of CSB will lead within only few generations to 
more tolerant spontaneous mutations due to enhanced biofilm formation properties. 
This emphasizes once again the importance of dealing with biofilms as a prime 
target for S.aureus therapies. The results also demonstrate that great care should be 
paid to the nowerdays very common use of metal impregnated materials, especially 
in hospitals. The more likely cross-resistance to antibiotics could exacerbate the 
situation of antibiotic resistance. 
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5.6 Usage of CSB as an anti-microbial polymer in healthcare domain 
As described above (Chapter: 1), this study is a part of EMBEK1 project. Aim of 
EMBEK1 project is to produce novel anti-microbial substances, which can be 
polymerised for variety of materials used in healthcare domain. Santo et al. (2012), 
demonstrated that copper based surfaces are effective in killing pathogenic bacteria 
like Staphylococcus haemolyticus (107). Therefore, copper based CSB monomer 
seems to be a good fit to be polymerised as an anti-microbial surface. Results of 
preliminary tests performed on CSB polymers by P.Cierniak et al and N. Poulter et 
al. showed that, CSB polymers were able to kill S.aureus effectively. As 
demonstrated in this study, anti-microbial effect of CSB monomer on S.aureus is 
seen at 0.6mM or higher concentration of CSB, which is considerably a high 
concentration as compared to the concentration required by other metallic complex 
based monomers like zinc (1, 66). It was also demonstrated that, only 135 
generations were required for an opportunistic bacteria like S.aureus to develop 
tolerance against CSB. Vuong et al. (2000), demonstrated that agr repressed 
S.aureus tend to adhere better to a polymer surface like polyesterene surface than 
the agr positive bacteria (37). Even though adhesion factor like clfA is reduced in 
ErCu , Vuong et al. hypothesize that down regulation of δ-toxin surfactant helps in 
better adhesion.of bacteria which exhibit  reduced expression of agr system like in 
case of ErCu (37, 108). δ-toxin is known to be a part of inflammatory polypeptide 
complex regulated by agr system, which acts as a surfactant and prevents 
adherence of bacterial cells to the surfaces (109). Therefore, decrease in agr 
expression also decreases the δ-toxin expression which facilitatates the adherence 
of bacterial cell to the surfaces (37, 110). However, for the better understanding, 
similar kind of study on CSB polymer is necessary. 
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7. APPENDIX
7.1 Superoxide anion measurement in MSSA476 and ErCu 
MSSA Mean Std er ErCu Mean Std er 
181.38 181.62 2.5111 84 79.71 2.645 
185.29 77.13 
178.2 78 
Table 4:  EB fluorescence of MSSA476 and ErCu strain grown in 0.5 mM CSB at 488 
nm excitation and 610-band pass filter. (Single measurement from 3 independent 
experiments). 
7.2 Cellular copper concentration measurement 
Strains sample 1 sample 2 sample 3 Mean Stdev Std er 
MSSA 
476 
9.12 9.18 10.2 9.5 0.60696 0.429185 
ErCu 8.92 7.75 8.46 8.376667 0.589435 0.416793 
Table 5: Measurement of cellular copper concentration in MSSA476 and ErCu strain 
grown in 0.5 mM CSB using ICP-MS. (Single measurement from 3 independent 
experiments). 
7.3 Gene expression measurement 
Gene MSSA  ErCu 
16S 
rRNA 
13,206 15,402 
13,592 18,651 
13,431 17,816 
AgrA 25,975 34,388 
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26,381 34,045 
26,842 34,475 
CopZ 23,349 29,833 
23,214 29,664 
23,234 29,785 
ClfA 23,116 31,000 
23,116 30,959 
23,738 31,072 
Spa 29,386 34,916 
29,385 34,513 
28,838 34,862 
Table 6: Cq values measured in qRT- PCR experiments for respective genes. 
Cq value is a n arbitrary units representing time taken to express the gene in the 
respective organism. Higher the Cq value, lower is the gene expression. Each gene 
expression is internally normalised by 16S rRNA gene and accordingly graph is 
created. The software qbase plus is used to normalise and generate the graph. 
Graphical representation is also based on an arbitory unit, with higher values for 
higher gene expression. 
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7.4 Biofilm formation assay 
Strains Sample 
1 
Sample 
2 
Sample 
3 
Sample 
4 
Mean Stdev Std er 
MSSA 
476 
15710.8
4 
13268.4
3 
13109.2
9 
14704.3
9 
14198.2
4 
1237.53
9 
714.493
2 
ErCu 17135.2
9 
18111.4
5 
18030.3 20027.2
8 
18326.0
8 
1217.32
1 
702.820
8 
Table 7: Optical density measurement of ErCu and MSSA476 strains stained 
with crystal violet (0.1%). 
7.5 PCR experiment to confirm the microevolved S.aureus 
Figure 16: Agrose gel electrophoresis showing amplified bands (Lane 1: 1Kb 
marker  ladder; Lane 2: 16S rRNA gene from MSSA476; Lane 3: Nuc gene from 
MSSA476; Lane 4: 16S rRNA from ErCu; Lane 5: Nuc gene from ErCu; Lane 6 
and 7: 16S rRNA gene and nuc gene respectively from S.carnosus; Lane 8,9 
and 10: Multiplex PCR products containing nuc gene and mecA gene from 
MSSA476, ErCu and S.Carnosus respectively). 
1 2 3 4 5 6 7 8 9 10 
Appendix 
84 
In the lane 4, DNA concentration used for PCR was much lesser than the other 
lanes. Hence, a very light intensity band can be seen. MecA gene was used 
check the presence of MRSA strain in multiplex PCR lane. 
7.6 Spectrometry MASCOT search data for 5 down regulated proteins from 2D-
DIGE experiments 
A) Mass spectrometry data MASCOT search results for Aspartyl/glutamyl‐tRNA
amidotransferase subunit A protein.  
 Mascot Search Results 
User : zba 
Email :  
Search title    :  HCT_bacteria_NCBI 
MS data file    : 5066549580983709.mgf 
Database : NCBInr 20100531 (11112683 sequences; 3786819628 residues) 
Taxonomy : Bacteria (Eubacteria) (6309942 sequences) 
Timestamp : 15 Jul 2010 at 09:26:14 GMT 
Protein 
hits 
 :
 gi|21
283570 
 aspartyl/glutamyl-tRNA amidotransferase subunit A 
[Staphylococcus aureus subsp. aureus MW2]
 gi|23
963804
3
 glutamyl-tRNA(Gln) amidotransferase subunit A 
[Staphylococcus warneri L37603]
 gi|27
468503 
 glutamyl-tRNAGln amidotransferase subunit A [Staphylococcus 
epidermidis ATCC 12228]
 gi|28
955038
2
 Aspartyl-tRNA(Asn) amidotransferase subunit A/Glutamyl-
tRNA(Gln) amidotransferase subunit A [Staphylococcus 
lugdunensis HKU09-01]
 gi|25
373054
1
 indole-3-pyruvate decarboxylase [Staphylococcus aureus 
subsp. aureus USA300_TCH959]
 gi|15
923157 
 aldehyde dehydrogenase-like protein [Staphylococcus aureus 
subsp. aureus Mu50]
 gi|15
924526 
 glycine dehydrogenase subunit 1 [Staphylococcus aureus 
subsp. aureus Mu50]
 gi|23
098220 
 aspartyl/glutamyl-tRNA amidotransferase subunit A 
[Oceanobacillus iheyensis HTE831]
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 gi|15
924086 
 dihydrolipoamide dehydrogenase [Staphylococcus aureus subsp. 
aureus Mu50]
Probability Based Mowse Score 
Figure 17: MS MASCOT data search probability based mowse score chart for 
Aspartyl/glutamyl‐tRNA amidotransferase subunit A protein. 
B) Mass spectrometry data MASCOT search results for Aldehyde
dehydrogenase like protein. 
 Mascot Search Results 
User : zba 
Email :  
Search title    :  HCT_bacteria_NCBI 
MS data file    : 5066549580983696.mgf 
Database : NCBInr 20100531 (11112683 sequences; 3786819628 residues) 
Taxonomy : Bacteria (Eubacteria) (6309942 sequences) 
Timestamp : 15 Jul 2010 at 07:32:19 GMT 
Protein 
hits    :
 gi|159
23157
 aldehyde dehydrogenase-like protein [Staphylococcus 
aureus subsp. aureus Mu50]
 gi|159
25112
 aldehyde dehydrogenase [Staphylococcus aureus subsp. 
aureus Mu50]
 gi|103
487892
 ABC transporter related [Sphingopyxis alaskensis RB2256]
 gi|260
221788
 Glycine-rich RNA-binding protein GRP1A [Curvibacter 
putative symbiont of Hydra magnipapillata]
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Probability Based Mowse Score 
Figure 18: MASCOT data search probability based mowse score chart for Aldehyde 
dehydrogenase like protein. 
C) Mass spectrometry data MASCOT search results for Inositol
monophosphate dehydrogenase protein. 
 Mascot Search Results 
User : zba 
Email :  
Search title    :  HCT_bacteria_NCBI 
MS data file    : 5066549580983622.mgf 
Database : NCBInr 20100531 (11112683 sequences; 3786819628 residues) 
Taxonomy : Bacteria (Eubacteria) (6309942 sequences) 
Timestamp : 14 Jul 2010 at 10:17:29 GMT 
Protein 
hits 
:
 gi|15
923380 
 inositol-monophosphate dehydrogenase [Staphylococcus aureus 
subsp. aureus Mu50]
 gi|70
727582 
 inositol-monophosphate dehydrogenase [Staphylococcus 
haemolyticus JCSC1435]
 gi|21
283404 
 formate--tetrahydrofolate ligase [Staphylococcus aureus 
subsp. aureus MW2]
 gi|89
100965 
 inositol-5-monophosphate dehydrogenase [Bacillus sp. NRRL B-
14911]
 gi|22
304309
4
 glycine dehydrogenase [decarboxylating] 
(Glycinedecarboxylase) (Glycine cleavage system P-protein) 
[Staphylococcus capitis SK14]
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Probability Based Mowse Score 
Figure 19: MS MASCOT data search probability based mowse score chart for 
Inositol monophosphate dehydrogenase protein.  
D) Mass spectrometry data MASCOT search results for Fumarate hydratase
protein. 
 Mascot Search Results 
User : zba 
Email :  
Search title    :  HCT_bacteria_NCBI 
MS data file    : 5066549580983697.mgf 
Database : NCBInr 20100531 (11112683 sequences; 3786819628 residues) 
Taxonomy : Bacteria (Eubacteria) (6309942 sequences) 
Timestamp : 15 Jul 2010 at 07:40:54 GMT 
Protein 
hits    :
 gi|25373
5269
 fumarate hydratase [Staphylococcus aureus subsp. 
aureus TCH130]
 gi|22447
6910
 fumarate hydratase, class-II [Staphylococcus carnosus 
subsp. carnosus TM300]
 gi|91787
923
 fumarate hydratase [Polaromonas sp. JS666]
 gi|23885
4888
 ComF operon protein 1 [Lactobacillus jensenii 269-3]
 gi|23801
9682
 hypothetical protein VEIDISOL_01556 [Veillonella 
dispar ATCC 17748]
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Probability Based Mowse Score 
Figure 20: MS MASCOT data search probability based mowse score chart for 
Fumarate hydratase protein. 
E) Mass spectrometry data MASCOT search results for Ornithine‐oxo‐acid
transaminase protein. 
 Mascot Search Results 
User : zba 
Email :  
Search title    :  HCT_bacteria_NCBI 
MS data file    : 5066549580983698.mgf 
Database : NCBInr 20100531 (11112683 sequences; 3786819628 residues) 
Taxonomy  : Bacteria (Eubacteria) (6309942 sequences) 
Timestamp : 15 Jul 2010 at 07:37:49 GMT 
Protein 
hits  :
 gi|1592
3947
 ornithine--oxo-acid transaminase [Staphylococcus aureus 
subsp. aureus Mu50]
 gi|2834
70156
 ornithine--oxo-acid transaminase [Staphylococcus aureus 
subsp. aureus ST398]
 gi|2518
10330
 ornithine--oxo-acid transaminase [Staphylococcus 
epidermidis BCM-HMP0060]
 gi|1592
3946
 putative NADH-dependent flavin oxidoreductase 
[Staphylococcus aureus subsp. aureus Mu50]
 gi|1608
1086
 ornithine--oxo-acid transaminase [Bacillus subtilis 
subsp. subtilis str. 168]
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Probability Based Mowse Score 
Figure 21: MS MASCOT data search probability based mowse score chart for 
Ornithine‐oxo‐acid transaminase protein. 
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Figure 22: Screen shot picture of list of Student’s T-test scores obtained by 
‘Decyder’ software for the down-regulated proteins from 2D-DIGE experiment 
7.7 Screen shot of student's T-test score from 2D-DIGE experiment 
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7.8 Protein expression data from nano LC-MALDI analysis 
Accessi
on 
Protein Scores Pept
ides 
Expre
ssion 
PUR1_S
TAAC 
Amidophosphoribosyltransferase OS=Staphylococcus aureus 
(strain COL) GN=purF PE=3 SV=1 
810 12 2.90 
RL36_S
TAA1 
50S ribosomal protein L36 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpmJ PE=3 SV=1 
52 1 2.34 
PUR5_S
TAAS 
Phosphoribosylformylglycinamidine cyclo-ligase 
OS=Staphylococcus aureus (strain MSSA476) GN=purM PE=3 
SV=1 
1002 16 2.16 
RS15_S
TAA1 
30S ribosomal protein S15 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsO PE=3 SV=1 
188 3 2.09 
PURQ_
STAAS 
Phosphoribosylformylglycinamidine synthase 1 
OS=Staphylococcus aureus (strain MSSA476) GN=purQ PE=3 
SV=1 
1115 15 2.09 
PUR2_S
TAAS 
Phosphoribosylamine--glycine ligase OS=Staphylococcus 
aureus (strain MSSA476) GN=purD PE=3 SV=1 
1216 19 2.04 
PUR9_S
TAA8 
Bifunctional purine biosynthesis protein purH 
OS=Staphylococcus aureus (strain NCTC 8325) GN=purH 
PE=3 SV=1 
1975 30 2.02 
PURL_S
TAAC 
Phosphoribosylformylglycinamidine synthase 2 
OS=Staphylococcus aureus (strain COL) GN=purL PE=3 SV=1 
2926 47 2.02 
PUR7_S
TAA1 
Phosphoribosylaminoimidazole-succinocarboxamide synthase 
OS=Staphylococcus aureus (strain Mu3 / ATCC 700698) 
GN=purC PE=3 SV=1 
868 13 1.81 
SARV_
STAAC 
HTH-type transcriptional regulator sarV OS=Staphylococcus 
aureus (strain COL) GN=sarV PE=3 SV=1 
444 9 1.80 
PUR8_S
TAA3 
Adenylosuccinate lyase OS=Staphylococcus aureus (strain 
USA300) GN=purB PE=3 SV=1 
1430 27 1.71 
PURK_
STAAM 
Phosphoribosylaminoimidazole carboxylase ATPase subunit 
OS=Staphylococcus aureus (strain Mu50 / ATCC 700699) 
GN=purK PE=1 SV=1 
578 11 1.71 
PUR3_S
TAAR 
Phosphoribosylglycinamide formyltransferase 
OS=Staphylococcus aureus (strain MRSA252) GN=purN PE=3 
SV=1 
282 5 1.65 
RL28_S
TAA1 
50S ribosomal protein L28 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpmB PE=3 SV=1 
161 3 1.61 
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PURA_
STAAC 
Adenylosuccinate synthetase OS=Staphylococcus aureus 
(strain COL) GN=purA PE=3 SV=1 
1460 22 1.60 
RL331_
STAAC 
50S ribosomal protein L33 1 OS=Staphylococcus aureus 
(strain COL) GN=rpmG1 PE=3 SV=1 
285 3 1.56 
RL15_S
TAA1 
50S ribosomal protein L15 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplO PE=3 SV=1 
476 6 1.55 
LDH1_S
TAAR 
L-lactate dehydrogenase 1 OS=Staphylococcus aureus (strain 
MRSA252) GN=ldh1 PE=3 SV=1 
814 12 1.54 
GLYA_
STAAT 
Serine hydroxymethyltransferase OS=Staphylococcus aureus 
(strain USA300 / TCH1516) GN=glyA PE=3 SV=1 
1452 26 1.54 
RS9_ST
AA1 
30S ribosomal protein S9 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsI PE=3 SV=1 
849 12 1.51 
GUAC_
STAAM 
GMP reductase OS=Staphylococcus aureus (strain Mu50 / 
ATCC 700699) GN=guaC PE=1 SV=1 
371 5 1.50 
PFLB_S
TAAB 
Formate acetyltransferase OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=pflB PE=3 SV=1 
1437 25 1.50 
GATA_
STAAS 
Glutamyl-tRNA(Gln) amidotransferase subunit A 
OS=Staphylococcus aureus (strain MSSA476) GN=gatA PE=3 
SV=1 
1152 15 1.49 
NTPA_S
TAAC 
Nucleoside-triphosphatase OS=Staphylococcus aureus (strain 
COL) GN=SACOL1162 PE=3 SV=1 
119 1 1.48 
DHA2_S
TAA3 
Alanine dehydrogenase 2 OS=Staphylococcus aureus (strain 
USA300) GN=ald2 PE=3 SV=1 
1429 22 1.43 
PYRC_
STAAC 
Dihydroorotase OS=Staphylococcus aureus (strain COL) 
GN=pyrC PE=3 SV=1 
426 6 1.42 
DAGK_
STAAB 
Diacylglycerol kinase OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=dagK PE=3 SV=1 
86 1 1.41 
RL20_S
TAA1 
50S ribosomal protein L20 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplT PE=3 SV=1 
265 5 1.41 
URK_S
TAAB 
Uridine kinase OS=Staphylococcus aureus (strain bovine 
RF122 / ET3-1) GN=udk PE=3 SV=1 
59 1 1.39 
RL30_S
TAA1 
50S ribosomal protein L30 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpmD PE=3 SV=1 
445 6 1.39 
RS12_S
TAA1 
30S ribosomal protein S12 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsL PE=3 SV=1 
565 11 1.38 
ATPA_S
TAAB 
ATP synthase subunit alpha OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=atpA PE=3 SV=1 
1390 22 1.38 
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PYRR_
STAAC 
Bifunctional protein pyrR OS=Staphylococcus aureus (strain 
COL) GN=pyrR PE=3 SV=1 
179 2 1.37 
IDH_ST
AAC 
Isocitrate dehydrogenase [NADP] OS=Staphylococcus aureus 
(strain COL) GN=icd PE=3 SV=1 
1476 25 1.36 
NDK_S
TAAS 
Nucleoside diphosphate kinase OS=Staphylococcus aureus 
(strain MSSA476) GN=ndk PE=3 SV=1 
672 9 1.36 
DTD_ST
AAB 
D-tyrosyl-tRNA(Tyr) deacylase OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=dtd PE=3 SV=1 
43 1 1.36 
Y811_S
TAAS 
NADH dehydrogenase-like protein SAS0811 
OS=Staphylococcus aureus (strain MSSA476) GN=SAS0811 
PE=3 SV=1 
1315 19 1.36 
COAE_
STAAR 
Dephospho-CoA kinase OS=Staphylococcus aureus (strain 
MRSA252) GN=coaE PE=3 SV=1 
123 2 1.35 
RL23_S
TAA1 
50S ribosomal protein L23 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplW PE=3 SV=1 
451 7 1.35 
RL2_ST
AA1 
50S ribosomal protein L2 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplB PE=3 SV=1 
910 12 1.35 
OTCC_
STAAC 
Ornithine carbamoyltransferase, catabolic OS=Staphylococcus 
aureus (strain COL) GN=arcB PE=3 SV=1 
468 8 1.33 
CSD_ST
AAC 
Probable cysteine desulfurase OS=Staphylococcus aureus 
(strain COL) GN=csd PE=3 SV=1 
167 2 1.32 
AZO1_S
TAA3 
FMN-dependent NADPH-azoreductase OS=Staphylococcus 
aureus (strain USA300) GN=azo1 PE=3 SV=1 
191 4 1.32 
RS10_S
TAA2 
30S ribosomal protein S10 OS=Staphylococcus aureus (strain 
JH1) GN=rpsJ PE=3 SV=1 
347 6 1.31 
DRP35_
STAA3 
Lactonase drp35 OS=Staphylococcus aureus (strain USA300) 
GN=drp35 PE=3 SV=2 
126 3 1.30 
ATPF_S
TAAB 
ATP synthase subunit b OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=atpF PE=3 SV=1 
445 5 1.30 
ADH_S
TAAB 
Alcohol dehydrogenase OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=adh PE=3 SV=1 
379 5 1.29 
FOLD_S
TAAC 
Bifunctional protein folD OS=Staphylococcus aureus (strain 
COL) GN=folD PE=3 SV=1 
1073 17 1.29 
MURA1
_STAA
C 
UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 
OS=Staphylococcus aureus (strain COL) GN=murA1 PE=3 
SV=1 
494 7 1.29 
RPOA_ DNA-directed RNA polymerase subunit alpha 955 16 1.28 
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STAAC OS=Staphylococcus aureus (strain COL) GN=rpoA PE=3 SV=1 
ATPE_S
TAAB 
ATP synthase epsilon chain OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=atpC PE=3 SV=1 
132 1 1.28 
RS3_ST
AA1 
30S ribosomal protein S3 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsC PE=3 SV=1 
1068 19 1.28 
RL22_S
TAA1 
50S ribosomal protein L22 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplV PE=3 SV=1 
364 5 1.28 
EFTU_S
TAAB 
Elongation factor Tu OS=Staphylococcus aureus (strain bovine 
RF122 / ET3-1) GN=tuf PE=3 SV=1 
3512 46 1.27 
QUEF_
STAAR 
NADPH-dependent 7-cyano-7-deazaguanine reductase 
OS=Staphylococcus aureus (strain MRSA252) GN=queF PE=3 
SV=1 
40 1 1.27 
GLNA_
STAAC 
Glutamine synthetase OS=Staphylococcus aureus (strain COL) 
GN=glnA PE=3 SV=1 
1977 26 1.26 
RL27_S
TAA1 
50S ribosomal protein L27 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpmA PE=3 SV=1 
403 6 1.26 
UPP_ST
AAB 
Uracil phosphoribosyltransferase OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=upp PE=3 SV=1 
892 12 1.26 
RS18_S
TAA1 
30S ribosomal protein S18 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsR PE=3 SV=1 
183 3 1.25 
RL14_S
TAA1 
50S ribosomal protein L14 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplN PE=3 SV=1 
459 9 1.25 
LDH2_S
TAA3 
L-lactate dehydrogenase 2 OS=Staphylococcus aureus (strain 
USA300) GN=ldh2 PE=3 SV=1 
1328 19 1.25 
RS4_ST
AA1 
30S ribosomal protein S4 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsD PE=3 SV=1 
1120 21 1.25 
RL19_S
TAA3 
50S ribosomal protein L19 OS=Staphylococcus aureus (strain 
USA300) GN=rplS PE=3 SV=1 
428 8 1.24 
CH10_S
TAA1 
10 kDa chaperonin OS=Staphylococcus aureus (strain Mu3 / 
ATCC 700698) GN=groS PE=3 SV=1 
320 6 1.24 
6PGD_S
TAAC 
6-phosphogluconate dehydrogenase, decarboxylating 
OS=Staphylococcus aureus (strain COL) GN=gnd PE=3 SV=1 
1420 24 1.24 
MURA2
_STAA
B 
UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=murA2 PE=3 SV=1 
314 4 1.23 
FTHS_S
TAAR 
Formate--tetrahydrofolate ligase OS=Staphylococcus aureus 
(strain MRSA252) GN=fhs PE=3 SV=1 
2030 31 1.23 
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SYS_ST
AAR 
Seryl-tRNA synthetase OS=Staphylococcus aureus (strain 
MRSA252) GN=serS PE=3 SV=1 
901 14 1.23 
ACON_
STAAC 
Aconitate hydratase OS=Staphylococcus aureus (strain COL) 
GN=acnA PE=3 SV=1 
3312 51 1.22! 
RL6_ST
AA1 
50S ribosomal protein L6 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplF PE=3 SV=1 
1238 16 1.22! 
HSLV_S
TAAB 
ATP-dependent protease subunit HslV OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=hslV PE=3 SV=1 
264 4 1.22 
RL29_S
TAA1 
50S ribosomal protein L29 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpmC PE=3 SV=1 
254 3 1.21 
GYRA_
STAAR 
DNA gyrase subunit A OS=Staphylococcus aureus (strain 
MRSA252) GN=gyrA PE=3 SV=1 
372 7 1.21 
GPMA_
STAAB 
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=gpmA PE=3 SV=1 
1002 15 1.21 
PCKA_
STAAS 
Phosphoenolpyruvate carboxykinase [ATP] 
OS=Staphylococcus aureus (strain MSSA476) GN=pckA PE=3 
SV=1 
2248 37 1.21 
PEPT_S
TAAR 
Peptidase T OS=Staphylococcus aureus (strain MRSA252) 
GN=pepT PE=3 SV=1 
240 5 1.21 
RL5_ST
AA1 
50S ribosomal protein L5 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplE PE=3 SV=1 
1378 23 1.21 
PDXT_S
TAAB 
Glutamine amidotransferase subunit pdxT OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=pdxT PE=3 SV=1 
514 8 1.21 
AMPM_
STAAC 
Methionine aminopeptidase OS=Staphylococcus aureus (strain 
COL) GN=map PE=3 SV=1 
315 3 1.20 
HUTI_S
TAAC 
Imidazolonepropionase OS=Staphylococcus aureus (strain 
COL) GN=hutI PE=3 SV=1 
582 9 1.20 
RS5_ST
AA1 
30S ribosomal protein S5 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsE PE=3 SV=1 
1000 14 1.20 
RS14Z_
STAA1 
30S ribosomal protein S14 type Z OS=Staphylococcus aureus 
(strain Mu3 / ATCC 700698) GN=rpsZ PE=3 SV=1 
80 2 1.20 
SECG_
STAAC 
Probable protein-export membrane protein secG 
OS=Staphylococcus aureus (strain COL) GN=secG PE=3 
SV=1 
119 1 1.20 
RS8_ST
AA1 
30S ribosomal protein S8 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsH PE=3 SV=1 
674 9 1.20 
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RL32_S
TAA1 
50S ribosomal protein L32 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpmF PE=3 SV=1 
196 2 1.19 
CARB_
STAAW 
Carbamoyl-phosphate synthase large chain 
OS=Staphylococcus aureus (strain MW2) GN=carB PE=3 
SV=1 
711 13 1.19 
RL21_S
TAAU 
50S ribosomal protein L21 OS=Staphylococcus aureus 
GN=rplU PE=3 SV=1 
669 7 1.18 
RBFA_
STAAB 
Ribosome-binding factor A OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=rbfA PE=3 SV=1 
117 2 1.18 
RL3_ST
AA1 
50S ribosomal protein L3 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplC PE=3 SV=1 
761 12 1.18 
PNP_ST
AAS 
Polyribonucleotide nucleotidyltransferase OS=Staphylococcus 
aureus (strain MSSA476) GN=pnp PE=3 SV=1 
1007 16 1.18 
SUCD_
STAAS 
Succinyl-CoA ligase [ADP-forming] subunit alpha 
OS=Staphylococcus aureus (strain MSSA476) GN=sucD PE=3 
SV=1 
1353 20 1.18 
TRXB_S
TAAC 
Thioredoxin reductase OS=Staphylococcus aureus (strain 
COL) GN=trxB PE=3 SV=1 
957 15 1.17 
DCUP_
STAAT 
Uroporphyrinogen decarboxylase OS=Staphylococcus aureus 
(strain USA300 / TCH1516) GN=hemE PE=3 SV=1 
291 6 1.17 
TIG_ST
AAC 
Trigger factor OS=Staphylococcus aureus (strain COL) GN=tig 
PE=3 SV=1 
1242 22 1.17 
EFTS_S
TAAM 
Elongation factor Ts OS=Staphylococcus aureus (strain Mu50 / 
ATCC 700699) GN=tsf PE=1 SV=1 
1820 28 1.17 
AHPF_S
TAAS 
Alkyl hydroperoxide reductase subunit F OS=Staphylococcus 
aureus (strain MSSA476) GN=ahpF PE=3 SV=1 
803 11 1.17 
RL31B_
STAA1 
50S ribosomal protein L31 type B OS=Staphylococcus aureus 
(strain Mu3 / ATCC 700698) GN=rpmE2 PE=3 SV=1 
639 10 1.17 
PYRH_
STAAB 
Uridylate kinase OS=Staphylococcus aureus (strain bovine 
RF122 / ET3-1) GN=pyrH PE=3 SV=1 
182 2 1.17 
LIPA_S
TAAB 
Lipoyl synthase OS=Staphylococcus aureus (strain bovine 
RF122 / ET3-1) GN=lipA PE=3 SV=1 
424 8 1.16 
CVFB_S
TAAB 
Conserved virulence factor B OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=cvfB PE=3 SV=1 
96 2 1.16 
RS7_ST
AA1 
30S ribosomal protein S7 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsG PE=3 SV=1 
800 13 1.16 
DNLJ_S DNA ligase OS=Staphylococcus aureus (strain bovine RF122 / 333 4 1.16 
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TAAB ET3-1) GN=ligA PE=3 SV=1 
DYR_ST
AAS 
Dihydrofolate reductase OS=Staphylococcus aureus (strain 
MSSA476) GN=folA PE=3 SV=3 
177 3 1.16 
LUKL1_
STAAB 
Uncharacterized leukocidin-like protein 1 OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=SAB1875c PE=3 
SV=1 
82 2 1.16 
ENGA_
STAAC 
GTP-binding protein engA OS=Staphylococcus aureus (strain 
COL) GN=engA PE=3 SV=1 
384 6 1.16 
G6PI_S
TAA3 
Glucose-6-phosphate isomerase OS=Staphylococcus aureus 
(strain USA300) GN=pgi PE=3 SV=1 
1492 28 1.15 
CH60_S
TAA1 
60 kDa chaperonin OS=Staphylococcus aureus (strain Mu3 / 
ATCC 700698) GN=groL PE=3 SV=1 
1845 25 1.15 
BINL_S
TAAU 
Transposon Tn552 resolvase OS=Staphylococcus aureus 
GN=tnpR PE=3 SV=1 
74 1 1.15 
PLSX_S
TAAR 
Phosphate acyltransferase OS=Staphylococcus aureus (strain 
MRSA252) GN=plsX PE=3 SV=1 
167 3 1.15 
ENGB_
STAAR 
Probable GTP-binding protein engB OS=Staphylococcus 
aureus (strain MRSA252) GN=engB PE=3 SV=1 
47 1 1.14 
RL17_S
TAA1 
50S ribosomal protein L17 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplQ PE=3 SV=1 
497 6 1.14 
FTSA_S
TAAR 
Cell division protein ftsA OS=Staphylococcus aureus (strain 
MRSA252) GN=ftsA PE=3 SV=1 
349 4 1.14 
HUTH_
STAAM 
Histidine ammonia-lyase OS=Staphylococcus aureus (strain 
Mu50 / ATCC 700699) GN=hutH PE=3 SV=1 
1037 18 1.14 
DNAK_
STAAC 
Chaperone protein dnaK OS=Staphylococcus aureus (strain 
COL) GN=dnaK PE=2 SV=1 
2404 32 1.14 
LDHD_
STAAC 
D-lactate dehydrogenase OS=Staphylococcus aureus (strain 
COL) GN=ldhD PE=3 SV=1 
503 9 1.13 
RS13_S
TAA1 
30S ribosomal protein S13 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsM PE=3 SV=1 
283 5 1.13 
GCH4_
STAAR 
GTP cyclohydrolase folE2 OS=Staphylococcus aureus (strain 
MRSA252) GN=folE2 PE=3 SV=1 
347 6 1.13 
RL1_ST
AAR 
50S ribosomal protein L1 OS=Staphylococcus aureus (strain 
MRSA252) GN=rplA PE=3 SV=1 
727 8 1.13 
WALR_
STAAB 
Transcriptional regulatory protein walR OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=walR PE=3 SV=2 
604 10 1.13 
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ATPB_S
TAAB 
ATP synthase subunit beta OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=atpD PE=3 SV=1 
2114 31 1.13 
PYRE_S
TAAS 
Orotate phosphoribosyltransferase OS=Staphylococcus aureus 
(strain MSSA476) GN=pyrE PE=3 SV=1 
286 6 1.12 
KAD_S
TAAC 
Adenylate kinase OS=Staphylococcus aureus (strain COL) 
GN=adk PE=3 SV=1 
794 11 1.12 
F16PC_
STAAS 
Fructose-1,6-bisphosphatase class 3 OS=Staphylococcus 
aureus (strain MSSA476) GN=fbp PE=3 SV=1 
1052 19 1.12 
RL18_S
TAA1 
50S ribosomal protein L18 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplR PE=3 SV=1 
592 9 1.12 
MURC_
STAAM 
UDP-N-acetylmuramate--L-alanine ligase OS=Staphylococcus 
aureus (strain Mu50 / ATCC 700699) GN=murC PE=1 SV=1 
577 8 1.12 
PYRB_
STAAC 
Aspartate carbamoyltransferase OS=Staphylococcus aureus 
(strain COL) GN=pyrB PE=3 SV=1 
178 4 1.12 
RL13_S
TAA1 
50S ribosomal protein L13 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplM PE=3 SV=1 
1179 19 1.12 
Y500_S
TAA9 
UPF0133 protein SaurJH9_0500 OS=Staphylococcus aureus 
(strain JH9) GN=SaurJH9_0500 PE=3 SV=1 
331 4 1.12 
RF3_ST
AAB 
Peptide chain release factor 3 OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=prfC PE=3 SV=1 
266 6 1.11 
GLMS_
STAAC 
Glucosamine--fructose-6-phosphate aminotransferase 
[isomerizing] OS=Staphylococcus aureus (strain COL) 
GN=glmS PE=3 SV=3 
1355 19 1.11 
RL24_S
TAA1 
50S ribosomal protein L24 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplX PE=3 SV=1 
128 2 1.11 
Y1737_
STAAN 
Uncharacterized protein SA1737 OS=Staphylococcus aureus 
(strain N315) GN=SA1737 PE=1 SV=1 
224 3 1.11 
EFG_ST
AAB 
Elongation factor G OS=Staphylococcus aureus (strain bovine 
RF122 / ET3-1) GN=fusA PE=3 SV=3 
3913 60 1.11 
SYI_ST
AAS 
Isoleucyl-tRNA synthetase OS=Staphylococcus aureus (strain 
MSSA476) GN=ileS PE=3 SV=1 
1036 18 1.11 
MQO2_
STAAC 
Probable malate:quinone oxidoreductase 2 
OS=Staphylococcus aureus (strain COL) GN=mqo2 PE=3 
SV=1 
2710 46 1.11 
TAGH_
STAAM 
Teichoic acids export ATP-binding protein TagH 
OS=Staphylococcus aureus (strain Mu50 / ATCC 700699) 
GN=tagH PE=1 SV=1 
205 3 1.10 
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SYG_ST
AAC 
Glycyl-tRNA synthetase OS=Staphylococcus aureus (strain 
COL) GN=glyQS PE=3 SV=1 
1274 19 1.10 
RL16_S
TAA1 
50S ribosomal protein L16 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplP PE=3 SV=1 
338 5 1.10 
Y1885_
STAAN 
Probable DEAD-box ATP-dependent RNA helicase SA1885 
OS=Staphylococcus aureus (strain N315) GN=SA1885 PE=1 
SV=1 
611 12 1.10 
RS2_ST
AA1 
30S ribosomal protein S2 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsB PE=3 SV=1 
1279 17 1.10 
HEM2_
STAA8 
Delta-aminolevulinic acid dehydratase OS=Staphylococcus 
aureus (strain NCTC 8325) GN=hemB PE=3 SV=1 
377 7 1.10 
BUTA_
STAAC 
Diacetyl reductase [(S)-acetoin forming] OS=Staphylococcus 
aureus (strain COL) GN=butA PE=3 SV=1 
246 3 1.10 
GRPE_
STAAC 
Protein grpE OS=Staphylococcus aureus (strain COL) 
GN=grpE PE=3 SV=1 
258 3 1.10 
Y408_S
TAAW 
UPF0753 protein MW0408 OS=Staphylococcus aureus (strain 
MW2) GN=MW0408 PE=3 SV=1 
41 1 1.10 
rndCLP
B_STA
AW 
Chaperone protein ClpB OS=Staphylococcus aureus (strain 
MW2) GN=clpB PE=3 SV=1 
71 2 1.09 
PANC_
STAAB 
Pantothenate synthetase OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=panC PE=3 SV=1 
201 2 1.09 
G3P2_S
TAAC 
Glyceraldehyde-3-phosphate dehydrogenase 2 
OS=Staphylococcus aureus (strain COL) GN=gapA2 PE=3 
SV=1 
1283 19 1.09 
PT1_ST
AAM 
Phosphoenolpyruvate-protein phosphotransferase 
OS=Staphylococcus aureus (strain Mu50 / ATCC 700699) 
GN=ptsI PE=1 SV=1 
1052 20 1.09 
CLPP_S
TAAB 
ATP-dependent Clp protease proteolytic subunit 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=clpP PE=3 SV=1 
378 7 1.09 
SYK_ST
AAS 
Lysyl-tRNA synthetase OS=Staphylococcus aureus (strain 
MSSA476) GN=lysS PE=3 SV=1 
977 18 1.09 
AROA_
STAAB 
3-phosphoshikimate 1-carboxyvinyltransferase 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=aroA PE=3 SV=1 
180 1 1.09 
FABH_
STAAC 
3-oxoacyl-[acyl-carrier-protein] synthase 3 OS=Staphylococcus 
aureus (strain COL) GN=fabH PE=3 SV=1 
295 5 1.08 
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Y2311_
STAAN 
Putative NAD(P)H nitroreductase SA2311 OS=Staphylococcus 
aureus (strain N315) GN=SA2311 PE=1 SV=1 
569 9 1.08 
RS11_S
TAA1 
30S ribosomal protein S11 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsK PE=3 SV=1 
543 5 1.08 
IF3_ST
AA8 
Translation initiation factor IF-3 OS=Staphylococcus aureus 
(strain NCTC 8325) GN=infC PE=3 SV=1 
345 3 1.08 
EFP_ST
AAB 
Elongation factor P OS=Staphylococcus aureus (strain bovine 
RF122 / ET3-1) GN=efp PE=3 SV=1 
343 6 1.08 
FTSZ_S
TAAC 
Cell division protein ftsZ OS=Staphylococcus aureus (strain 
COL) GN=ftsZ PE=3 SV=1 
2344 30 1.08 
FABG_
STAAC 
3-oxoacyl-[acyl-carrier-protein] reductase OS=Staphylococcus 
aureus (strain COL) GN=fabG PE=3 SV=2 
1025 12 1.08 
CARA_
STAAC 
Carbamoyl-phosphate synthase small chain 
OS=Staphylococcus aureus (strain COL) GN=carA PE=3 SV=1 
212 4 1.07 
TRAP_S
TAAS 
Signal transduction protein TRAP OS=Staphylococcus aureus 
(strain MSSA476) GN=traP PE=3 SV=1 
471 8 1.07 
SSB_ST
AAC 
Single-stranded DNA-binding protein OS=Staphylococcus 
aureus (strain COL) GN=ssb PE=3 SV=1 
643 8 1.07 
CLPX_S
TAAB 
ATP-dependent Clp protease ATP-binding subunit clpX 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=clpX PE=3 SV=1 
284 6 1.07 
DUS_ST
AAC 
Probable tRNA-dihydrouridine synthase OS=Staphylococcus 
aureus (strain COL) GN=dus PE=3 SV=2 
102 2 1.07 
DHE2_S
TAAC 
NAD-specific glutamate dehydrogenase OS=Staphylococcus 
aureus (strain COL) GN=gluD PE=3 SV=1 
1585 22 1.07 
FUMC_
STAAC 
Fumarate hydratase class II OS=Staphylococcus aureus (strain 
COL) GN=fumC PE=3 SV=1 
815 14 1.07 
ILVE_S
TAAC 
Probable branched-chain-amino-acid aminotransferase 
OS=Staphylococcus aureus (strain COL) GN=ilvE PE=3 SV=1 
778 13 1.06 
SUCC_
STAAC 
Succinyl-CoA ligase [ADP-forming] subunit beta 
OS=Staphylococcus aureus (strain COL) GN=sucC PE=3 
SV=1 
1735 28 1.06 
FABF_S
TAAC 
3-oxoacyl-[acyl-carrier-protein] synthase 2 OS=Staphylococcus 
aureus (strain COL) GN=fabF PE=1 SV=1 
1047 17 1.06 
SODM1
_STAA3 
Superoxide dismutase [Mn/Fe] 1 OS=Staphylococcus aureus 
(strain USA300) GN=sodA PE=3 SV=1 
775 9 1.06 
PRSA_ Foldase protein prsA OS=Staphylococcus aureus (strain 399 7 1.06 
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STAAR MRSA252) GN=prsA PE=3 SV=1 
SYD_ST
AAR 
Aspartyl-tRNA synthetase OS=Staphylococcus aureus (strain 
MRSA252) GN=aspS PE=3 SV=1 
854 15 1.06 
ISPD1_
STAAS 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1 
OS=Staphylococcus aureus (strain MSSA476) GN=ispD1 
PE=3 SV=1 
496 7 1.06 
PYRG_
STAA8 
CTP synthase OS=Staphylococcus aureus (strain NCTC 8325) 
GN=pyrG PE=3 SV=1 
920 14 1.06 
MAZF_
STAAB 
Toxin mazF OS=Staphylococcus aureus (strain bovine RF122 / 
ET3-1) GN=mazF PE=3 SV=1 
49 1 1.05 
Y989_S
TAAW 
UPF0637 protein MW0989 OS=Staphylococcus aureus (strain 
MW2) GN=MW0989 PE=3 SV=1 
208 3 1.05 
Y1178_
STAAN 
UPF0154 protein SA1178 OS=Staphylococcus aureus (strain 
N315) GN=SA1178 PE=1 SV=1 
84 2 1.05 
MSRA2
_STAA
R 
Peptide methionine sulfoxide reductase msrA 2 
OS=Staphylococcus aureus (strain MRSA252) GN=msrA2 
PE=3 SV=1 
261 4 1.05 
SYT_ST
AAM 
Threonyl-tRNA synthetase OS=Staphylococcus aureus (strain 
Mu50 / ATCC 700699) GN=thrS PE=1 SV=1 
1458 26 1.05 
SYV_ST
AAR 
Valyl-tRNA synthetase OS=Staphylococcus aureus (strain 
MRSA252) GN=valS PE=3 SV=1 
639 11 1.05 
QOX1_
STAAR 
Probable quinol oxidase subunit 1 OS=Staphylococcus aureus 
(strain MRSA252) GN=qoxB PE=3 SV=1 
179 3 1.05 
RNJ1_S
TAAB 
Ribonuclease J 1 OS=Staphylococcus aureus (strain bovine 
RF122 / ET3-1) GN=SAB0955c PE=3 SV=1 
704 10 1.04 
SYH_ST
AAB 
Histidyl-tRNA synthetase OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=hisS PE=3 SV=1 
94 2 1.04 
RS6_ST
AA1 
30S ribosomal protein S6 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsF PE=3 SV=1 
864 17 1.04 
ATPG_
STAAC 
ATP synthase gamma chain OS=Staphylococcus aureus 
(strain COL) GN=atpG PE=3 SV=1 
609 11 1.04 
Y1090_
STAAB 
Uncharacterized protein SAB1090 OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=SAB1090 PE=4 SV=1 
617 10 1.04 
RS1_ST
AAC 
30S ribosomal protein S1 OS=Staphylococcus aureus (strain 
COL) GN=rpsA PE=3 SV=1 
1129 16 1.04 
AZOR_
STAAB 
FMN-dependent NADH-azoreductase OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=azoR PE=3 SV=2 
193 4 1.04 
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GATB_
STAAB 
Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=gatB PE=3 SV=1 
1171 20 1.04 
RL4_ST
AA1 
50S ribosomal protein L4 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplD PE=3 SV=1 
763 10 1.04 
VRAR_
STAAC 
Response regulator protein vraR OS=Staphylococcus aureus 
(strain COL) GN=vraR PE=3 SV=1 
73 1 1.04 
RS16_S
TAA1 
30S ribosomal protein S16 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsP PE=3 SV=1 
459 8 1.04 
RPOC_
STAAC 
DNA-directed RNA polymerase subunit beta' 
OS=Staphylococcus aureus (strain COL) GN=rpoC PE=3 SV=1 
2296 40 1.04 
PTLA_S
TAAC 
Lactose-specific phosphotransferase enzyme IIA component 
OS=Staphylococcus aureus (strain COL) GN=lacF PE=3 SV=1 
66 1 1.03 
GCSPB
_STAAS 
Probable glycine dehydrogenase [decarboxylating] subunit 2 
OS=Staphylococcus aureus (strain MSSA476) GN=gcvPB 
PE=3 SV=1 
1204 20 1.03 
DLTA_S
TAAR 
D-alanine--poly(phosphoribitol) ligase subunit 1 
OS=Staphylococcus aureus (strain MRSA252) GN=dltA PE=3 
SV=1 
474 8 1.03 
RS19_S
TAA1 
30S ribosomal protein S19 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsS PE=3 SV=1 
444 6 1.03 
SYL_ST
AAB 
Leucyl-tRNA synthetase OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=leuS PE=3 SV=1 
437 8 1.03 
METK_
STAAR 
S-adenosylmethionine synthase OS=Staphylococcus aureus 
(strain MRSA252) GN=metK PE=3 SV=1 
651 11 1.03 
SAER_
STAAB 
Response regulator saeR OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=saeR PE=3 SV=1 
154 3 1.03 
GPDA_
STAAC 
Glycerol-3-phosphate dehydrogenase [NAD(P)+] 
OS=Staphylococcus aureus (strain COL) GN=gpsA PE=3 
SV=1 
240 2 1.03 
RS17_S
TAA1 
30S ribosomal protein S17 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsQ PE=3 SV=1 
226 5 1.02 
FABD_
STAAS 
Malonyl CoA-acyl carrier protein transacylase 
OS=Staphylococcus aureus (strain MSSA476) GN=fabD PE=3 
SV=1 
314 3 1.02 
DAPA_
STAAB 
Dihydrodipicolinate synthase OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=dapA PE=3 SV=1 
52 1 1.02 
NUSB_ N utilization substance protein B homolog OS=Staphylococcus 87 2 1.02 
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STAAB aureus (strain bovine RF122 / ET3-1) GN=nusB PE=3 SV=1 
ATPD_S
TAAR 
ATP synthase subunit delta OS=Staphylococcus aureus (strain 
MRSA252) GN=atpH PE=3 SV=1 
536 8 1.01 
SRRA_
STAAC 
Transcriptional regulatory protein srrA OS=Staphylococcus 
aureus (strain COL) GN=srrA PE=2 SV=1 
519 8 1.01 
RF1_ST
AAB 
Peptide chain release factor 1 OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=prfA PE=3 SV=1 
135 3 1.01 
RL11_S
TAAB 
50S ribosomal protein L11 OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=rplK PE=3 SV=3 
516 10 1.01 
ODP2_S
TAAM 
Dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex OS=Staphylococcus aureus 
(strain Mu50 / ATCC 700699) GN=pdhC PE=1 SV=1 
1772 23 1.01 
SYE_ST
AAM 
Glutamyl-tRNA synthetase OS=Staphylococcus aureus (strain 
Mu50 / ATCC 700699) GN=gltX PE=1 SV=1 
1112 20 1.01 
ALF2_S
TAAC 
Fructose-bisphosphate aldolase OS=Staphylococcus aureus 
(strain COL) GN=fba PE=3 SV=1 
1048 18 1.01 
GLMM_
STAAC 
Phosphoglucosamine mutase OS=Staphylococcus aureus 
(strain COL) GN=glmM PE=1 SV=1 
822 16 1.00 
OBG_S
TAAC 
GTPase obg OS=Staphylococcus aureus (strain COL) GN=obg 
PE=3 SV=1 
173 3 1.00 
IF1_ST
AA1 
Translation initiation factor IF-1 OS=Staphylococcus aureus 
(strain Mu3 / ATCC 700698) GN=infA PE=3 SV=1 
366 7 1.00 
NUSG_
STAAC 
Transcription antitermination protein nusG OS=Staphylococcus 
aureus (strain COL) GN=nusG PE=3 SV=1 
307 5 1.00 
SYFB_S
TAAS 
Phenylalanyl-tRNA synthetase beta chain OS=Staphylococcus 
aureus (strain MSSA476) GN=pheT PE=3 SV=1 
609 12 1.00 
SYP_ST
AAS 
Prolyl-tRNA synthetase OS=Staphylococcus aureus (strain 
MSSA476) GN=proS PE=3 SV=1 
860 13 1.00 
QOX2_
STAA3 
Probable quinol oxidase subunit 2 OS=Staphylococcus aureus 
(strain USA300) GN=qoxA PE=3 SV=1 
863 16 1.00 
SARR_
STAAB 
HTH-type transcriptional regulator sarR OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=sarR PE=3 SV=3 
338 5 1.00 
ACCA_
STAAM 
Acetyl-coenzyme A carboxylase carboxyl transferase subunit 
alpha OS=Staphylococcus aureus (strain Mu50 / ATCC 
700699) GN=accA PE=1 SV=1 
120 3 0.99 
RNC_S
TAAM 
Ribonuclease 3 OS=Staphylococcus aureus (strain Mu50 / 
ATCC 700699) GN=rnc PE=3 SV=1 
125 1 0.99 
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GLPK_
STAAW 
Glycerol kinase OS=Staphylococcus aureus (strain MW2) 
GN=glpK PE=3 SV=1 
1405 21 0.99 
GLPD_
STAAC 
Aerobic glycerol-3-phosphate dehydrogenase 
OS=Staphylococcus aureus (strain COL) GN=glpD PE=3 SV=1 
543 9 0.99 
DAAA_
STAAS 
D-alanine aminotransferase OS=Staphylococcus aureus (strain 
MSSA476) GN=dat PE=3 SV=1 
899 15 0.99 
Y778_S
TAAN 
UPF0051 protein SA0778 OS=Staphylococcus aureus (strain 
N315) GN=SA0778 PE=1 SV=1 
742 14 0.99 
ODO1_
STAAN 
2-oxoglutarate dehydrogenase E1 component 
OS=Staphylococcus aureus (strain N315) GN=odhA PE=1 
SV=1 
2427 41 0.99 
SYY_ST
AAC 
Tyrosyl-tRNA synthetase OS=Staphylococcus aureus (strain 
COL) GN=tyrS PE=3 SV=1 
119 3 0.99 
GCSPA
_STAA
M 
Probable glycine dehydrogenase [decarboxylating] subunit 1 
OS=Staphylococcus aureus (strain Mu50 / ATCC 700699) 
GN=gcvPA PE=1 SV=1 
1391 18 0.99 
APT_ST
AAB 
Adenine phosphoribosyltransferase OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=apt PE=3 SV=1 
49 1 0.99 
PDXS_S
TAAC 
Pyridoxal biosynthesis lyase pdxS OS=Staphylococcus aureus 
(strain COL) GN=pdxS PE=3 SV=1 
1517 24 0.99 
RPOB_
STAAR 
DNA-directed RNA polymerase subunit beta 
OS=Staphylococcus aureus (strain MRSA252) GN=rpoB PE=3 
SV=1 
1860 35 0.99 
RPOD_
STAAN 
RNA polymerase sigma factor rpoD OS=Staphylococcus 
aureus (strain N315) GN=rpoD PE=1 SV=1 
151 3 0.98 
BIKB_S
TAAM 
Putative 8-amino-7-oxononanoate synthase/2-amino-3-
ketobutyrate coenzyme A ligase OS=Staphylococcus aureus 
(strain Mu50 / ATCC 700699) GN=SAV0550 PE=1 SV=1 
1770 26 0.98 
SECA_
STAAB 
Protein translocase subunit secA OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=secA PE=3 SV=1 
773 13 0.98 
SYC_ST
AAS 
Cysteinyl-tRNA synthetase OS=Staphylococcus aureus (strain 
MSSA476) GN=cysS PE=3 SV=1 
613 9 0.98 
Y2196_
STAAS 
Putative 2-hydroxyacid dehydrogenase SAS2196 
OS=Staphylococcus aureus (strain MSSA476) GN=SAS2196 
PE=3 SV=1 
1221 17 0.98 
MURE_
STAAS 
UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--L-lysine ligase 
OS=Staphylococcus aureus (strain MSSA476) GN=murE PE=3 
SV=1 
231 4 0.98 
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MNMA_
STAAM 
tRNA-specific 2-thiouridylase mnmA OS=Staphylococcus 
aureus (strain Mu50 / ATCC 700699) GN=mnmA PE=1 SV=1 
165 3 0.98 
FTN_ST
AAB 
Ferritin OS=Staphylococcus aureus (strain bovine RF122 / 
ET3-1) GN=ftnA PE=3 SV=1 
640 11 0.98 
EZRA_S
TAAB 
Septation ring formation regulator ezrA OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=ezrA PE=3 SV=1 
512 6 0.97 
FABZ_S
TAAB 
(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=fabZ PE=3 SV=1 
256 4 0.97 
FOLB_S
TAAC 
Dihydroneopterin aldolase OS=Staphylococcus aureus (strain 
COL) GN=folB PE=3 SV=1 
75 1 0.97 
PTA_ST
AAS 
Phosphate acetyltransferase OS=Staphylococcus aureus 
(strain MSSA476) GN=pta PE=3 SV=1 
1096 17 0.97 
Y829_S
TAAN 
Uncharacterized protein SA0829 OS=Staphylococcus aureus 
(strain N315) GN=SA0829 PE=1 SV=1 
1549 23 0.97 
PPAC_
STAAB 
Probable manganese-dependent inorganic pyrophosphatase 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=ppaC PE=3 SV=1 
965 14 0.97 
TELL_S
TAAS 
TelA-like protein SAS1347 OS=Staphylococcus aureus (strain 
MSSA476) GN=SAS1347 PE=3 SV=1 
221 4 0.97 
ENO_S
TAAB 
Enolase OS=Staphylococcus aureus (strain bovine RF122 / 
ET3-1) GN=eno PE=3 SV=1 
1939 29 0.96 
DLDH_
STAAC 
Dihydrolipoyl dehydrogenase OS=Staphylococcus aureus 
(strain COL) GN=pdhD PE=3 SV=1 
1940 29 0.96 
Y1302_
STAA3 
Uncharacterized protein SAUSA300_1302 OS=Staphylococcus 
aureus (strain USA300) GN=SAUSA300_1302 PE=3 SV=1 
202 5 0.96 
Y593_S
TAAR 
UPF0447 protein SAR0593 OS=Staphylococcus aureus (strain 
MRSA252) GN=SAR0593 PE=3 SV=1 
390 5 0.96 
LEP_ST
AAC 
Signal peptidase IB OS=Staphylococcus aureus (strain COL) 
GN=spsB PE=3 SV=2 
310 4 0.95 
MENB_
STAAS 
Naphthoate synthase OS=Staphylococcus aureus (strain 
MSSA476) GN=menB PE=3 SV=1 
1293 22 0.95 
RS21_S
TAA1 
30S ribosomal protein S21 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsU PE=3 SV=1 
123 2 0.95 
SARA_
STAAB 
Transcriptional regulator sarA OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=sarA PE=3 SV=1 
470 7 0.95 
ERA_ST GTP-binding protein era homolog OS=Staphylococcus aureus 352 8 0.95 
 
Appendix 
 
 
 
106 
 
AAB (strain bovine RF122 / ET3-1) GN=era PE=3 SV=1 
RL25_S
TAA3 
50S ribosomal protein L25 OS=Staphylococcus aureus (strain 
USA300) GN=rplY PE=3 SV=1 
791 12 0.95 
GYRB_
STAAC 
DNA gyrase subunit B OS=Staphylococcus aureus (strain 
COL) GN=gyrB PE=3 SV=3 
322 4 0.94 
Y618_S
TAAB 
UPF0082 protein SAB0618 OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=SAB0618 PE=3 SV=1 
469 6 0.94 
ACKA_
STAAB 
Acetate kinase OS=Staphylococcus aureus (strain bovine 
RF122 / ET3-1) GN=ackA PE=3 SV=1 
831 15 0.94 
MQO1_
STAAM 
Probable malate:quinone oxidoreductase 1 
OS=Staphylococcus aureus (strain Mu50 / ATCC 700699) 
GN=mqo1 PE=1 SV=1 
266 6 0.94 
CLS1_S
TAAC 
Cardiolipin synthase 1 OS=Staphylococcus aureus (strain 
COL) GN=cls1 PE=3 SV=1 
92 2 0.94 
CCPA_
STAAC 
Probable catabolite control protein A OS=Staphylococcus 
aureus (strain COL) GN=ccpA PE=3 SV=1 
616 10 0.94 
PGCA_
STAAM 
Phosphoglucomutase OS=Staphylococcus aureus (strain Mu50 
/ ATCC 700699) GN=pgcA PE=1 SV=2 
205 4 0.94 
TKT_ST
AAC 
Transketolase OS=Staphylococcus aureus (strain COL) GN=tkt 
PE=3 SV=1 
1293 20 0.93 
Y1195_
STAAN 
Probable tautomerase SA1195.1 OS=Staphylococcus aureus 
(strain N315) GN=SA1195.1 PE=1 SV=2 
232 4 0.93 
KITH_S
TAAM 
Thymidine kinase OS=Staphylococcus aureus (strain Mu50 / 
ATCC 700699) GN=tdk PE=3 SV=1 
118 3 0.93 
DPO3B
_STAA
C 
DNA polymerase III subunit beta OS=Staphylococcus aureus 
(strain COL) GN=dnaN PE=3 SV=1 
485 11 0.93 
IF2_ST
AAS 
Translation initiation factor IF-2 OS=Staphylococcus aureus 
(strain MSSA476) GN=infB PE=3 SV=1 
993 13 0.93 
MURB_
STAAR 
UDP-N-acetylenolpyruvoylglucosamine reductase 
OS=Staphylococcus aureus (strain MRSA252) GN=murB PE=3 
SV=1 
236 5 0.93 
Y1541_
STAAS 
UPF0271 protein SAS1541 OS=Staphylococcus aureus (strain 
MSSA476) GN=SAS1541 PE=3 SV=1 
85 1 0.93 
TOP1_S
TAAM 
DNA topoisomerase 1 OS=Staphylococcus aureus (strain 
Mu50 / ATCC 700699) GN=topA PE=3 SV=1 
192 4 0.93 
HUTU_ Urocanate hydratase OS=Staphylococcus aureus (strain COL) 508 9 0.93 
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STAAC GN=hutU PE=3 SV=1 
MSRB_
STAAE 
Peptide methionine sulfoxide reductase msrB 
OS=Staphylococcus aureus (strain Newman) GN=msrB PE=3 
SV=1 
195 3 0.93 
LEPA_S
TAAC 
GTP-binding protein lepA OS=Staphylococcus aureus (strain 
COL) GN=lepA PE=3 SV=1 
471 9 0.92 
RL10_S
TAAS 
50S ribosomal protein L10 OS=Staphylococcus aureus (strain 
MSSA476) GN=rplJ PE=3 SV=1 
574 5 0.92 
Y508_S
TAAW 
Uncharacterized epimerase/dehydratase MW0508 
OS=Staphylococcus aureus (strain MW2) GN=MW0508 PE=3 
SV=1 
533 9 0.92 
MTNN_
STAAB 
5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=mtnN PE=3 SV=1 
100 1 0.92 
MURG_
STAAC 
UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-acetylglucosamine transferase 
OS=Staphylococcus aureus (strain COL) GN=murG PE=3 
SV=1 
458 8 0.92 
ARGI_S
TAAC 
Arginase OS=Staphylococcus aureus (strain COL) GN=arg 
PE=3 SV=1 
322 4 0.92 
CYSK_
STAAC 
Cysteine synthase OS=Staphylococcus aureus (strain COL) 
GN=cysK PE=3 SV=1 
2191 28 0.92 
ISPD2_
STAAC 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 2 
OS=Staphylococcus aureus (strain COL) GN=ispD2 PE=3 
SV=1 
600 13 0.92 
PYRF_S
TAAC 
Orotidine 5'-phosphate decarboxylase OS=Staphylococcus 
aureus (strain COL) GN=pyrF PE=3 SV=1 
345 5 0.91 
SYA_ST
AAS 
Alanyl-tRNA synthetase OS=Staphylococcus aureus (strain 
MSSA476) GN=alaS PE=3 SV=1 
821 14 0.91 
PEPVL_
STAAB 
Putative dipeptidase SAB1611c OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=SAB1611c PE=3 SV=1 
971 16 0.91 
GCST_
STAAR 
Aminomethyltransferase OS=Staphylococcus aureus (strain 
MRSA252) GN=gcvT PE=3 SV=1 
1182 20 0.91 
DNAJ_S
TAAU 
Chaperone protein dnaJ OS=Staphylococcus aureus GN=dnaJ 
PE=3 SV=1 
70 1 0.91 
GPMI_S
TAAC 
2,3-bisphosphoglycerate-independent phosphoglycerate 
mutase OS=Staphylococcus aureus (strain COL) GN=gpmI 
PE=3 SV=1 
721 12 0.91 
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HSLO_
STAAM 
33 kDa chaperonin OS=Staphylococcus aureus (strain Mu50 / 
ATCC 700699) GN=hslO PE=1 SV=1 
111 2 0.91 
END4_S
TAA3 
Probable endonuclease 4 OS=Staphylococcus aureus (strain 
USA300) GN=nfo PE=3 SV=1 
155 3 0.91 
DHPS_
STAAR 
Dihydropteroate synthase OS=Staphylococcus aureus (strain 
MRSA252) GN=folP PE=3 SV=1 
63 1 0.91 
Y1530_
STAAN 
Uncharacterized peptidase SA1530 OS=Staphylococcus 
aureus (strain N315) GN=SA1530 PE=1 SV=2 
225 5 0.91 
CLPC_S
TAAC 
ATP-dependent Clp protease ATP-binding subunit clpC 
OS=Staphylococcus aureus (strain COL) GN=clpC PE=3 SV=1 
678 13 0.91 
Y704_S
TAAB 
Uncharacterized protein SAB0704 OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=SAB0704 PE=3 SV=1 
760 10 0.91 
DEOC2
_STAA
C 
Deoxyribose-phosphate aldolase 2 OS=Staphylococcus aureus 
(strain COL) GN=deoC2 PE=3 SV=1 
575 7 0.91 
ACCD_
STAAS 
Acetyl-coenzyme A carboxylase carboxyl transferase subunit 
beta OS=Staphylococcus aureus (strain MSSA476) GN=accD 
PE=3 SV=1 
116 2 0.90 
SYN_ST
AAB 
Asparaginyl-tRNA synthetase OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=asnS PE=3 SV=1 
635 11 0.90 
ODPA_
STAAC 
Pyruvate dehydrogenase E1 component subunit alpha 
OS=Staphylococcus aureus (strain COL) GN=pdhA PE=3 
SV=1 
1603 27 0.90 
ARGR_
STAAB 
Arginine repressor OS=Staphylococcus aureus (strain bovine 
RF122 / ET3-1) GN=argR PE=3 SV=1 
164 1 0.90 
KPYK_
STAAC 
Pyruvate kinase OS=Staphylococcus aureus (strain COL) 
GN=pyk PE=3 SV=1 
1578 19 0.90 
TGT_ST
AAB 
Queuine tRNA-ribosyltransferase OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=tgt PE=3 SV=1 
144 2 0.90 
SYR_ST
AAR 
Arginyl-tRNA synthetase OS=Staphylococcus aureus (strain 
MRSA252) GN=argS PE=3 SV=1 
890 12 0.90 
HPRK_
STAAB 
HPr kinase/phosphorylase OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=hprK PE=3 SV=1 
214 4 0.90 
Y1727_
STAAN 
UPF0316 protein SA1727 OS=Staphylococcus aureus (strain 
N315) GN=SA1727 PE=1 SV=1 
97 2 0.89 
ADDA_
STAAR 
ATP-dependent helicase/nuclease subunit A 
OS=Staphylococcus aureus (strain MRSA252) GN=addA PE=3 
SV=1 
107 2 0.89 
 
Appendix 
 
 
 
109 
 
HEMH_
STAAR 
Ferrochelatase OS=Staphylococcus aureus (strain MRSA252) 
GN=hemH PE=3 SV=1 
145 4 0.89 
TRMFO
_STAA2 
Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase 
trmFO OS=Staphylococcus aureus (strain JH1) GN=trmFO 
PE=3 SV=1 
224 3 0.89 
HEM3_
STAAB 
Porphobilinogen deaminase OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=hemC PE=3 SV=1 
111 2 0.89 
DDL_ST
AAS 
D-alanine--D-alanine ligase OS=Staphylococcus aureus (strain 
MSSA476) GN=ddl PE=3 SV=1 
404 7 0.89 
PTPA_S
TAAR 
Low molecular weight protein-tyrosine-phosphatase ptpA 
OS=Staphylococcus aureus (strain MRSA252) GN=ptpA PE=3 
SV=1 
197 3 0.89 
PANB_
STAAB 
3-methyl-2-oxobutanoate hydroxymethyltransferase 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=panB PE=3 SV=1 
289 4 0.89 
PGK_S
TAAB 
Phosphoglycerate kinase OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=pgk PE=3 SV=1 
732 12 0.88 
UREE_
STAAR 
Urease accessory protein ureE OS=Staphylococcus aureus 
(strain MRSA252) GN=ureE PE=3 SV=1 
44 1 0.88 
HPRT_S
TAAC 
Hypoxanthine-guanine phosphoribosyltransferase 
OS=Staphylococcus aureus (strain COL) GN=hpt PE=3 SV=1 
362 5 0.88 
PDXK_
STAAC 
Putative pyridoxine kinase OS=Staphylococcus aureus (strain 
COL) GN=pdxK PE=3 SV=1 
147 3 0.88 
RS20_S
TAA1 
30S ribosomal protein S20 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rpsT PE=3 SV=1 
311 5 0.88 
RISB_S
TAAB 
6,7-dimethyl-8-ribityllumazine synthase OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=ribH PE=3 SV=1 
181 3 0.88 
RL9_ST
AA1 
50S ribosomal protein L9 OS=Staphylococcus aureus (strain 
Mu3 / ATCC 700698) GN=rplI PE=3 SV=1 
274 5 0.88 
CDR_S
TAA8 
Coenzyme A disulfide reductase OS=Staphylococcus aureus 
(strain NCTC 8325) GN=cdr PE=1 SV=3 
315 4 0.88 
NAGD_
STAAC 
Protein nagD homolog OS=Staphylococcus aureus (strain 
COL) GN=nagD PE=3 SV=1 
227 4 0.87 
RSMA_
STAAE 
Ribosomal RNA small subunit methyltransferase A 
OS=Staphylococcus aureus (strain Newman) GN=rsmA PE=3 
SV=1 
64 1 0.87 
CATA_
STAAB 
Catalase OS=Staphylococcus aureus (strain bovine RF122 / 
ET3-1) GN=katA PE=3 SV=2 
1783 29 0.87 
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Y1560_
STAAN 
UPF0478 protein SA1560 OS=Staphylococcus aureus (strain 
N315) GN=SA1560 PE=1 SV=1 
852 10 0.87 
RNJ2_S
TAA3 
Ribonuclease J 2 OS=Staphylococcus aureus (strain USA300) 
GN=SAUSA300_1168 PE=3 SV=2 
269 3 0.87 
SECY_S
TAAC 
Preprotein translocase subunit secY OS=Staphylococcus 
aureus (strain COL) GN=secY PE=3 SV=1 
49 1 0.87 
URE1_S
TAAR 
Urease subunit alpha OS=Staphylococcus aureus (strain 
MRSA252) GN=ureC PE=3 SV=1 
100 2 0.86 
FDHL_S
TAAC 
Putative formate dehydrogenase SACOL2301 
OS=Staphylococcus aureus (strain COL) GN=SACOL2301 
PE=3 SV=1 
517 11 0.86 
KPRS_
STAAC 
Ribose-phosphate pyrophosphokinase OS=Staphylococcus 
aureus (strain COL) GN=prs PE=3 SV=1 
640 8 0.86 
YSI3_S
TAAU 
Putative phosphotransferase in Sigma70 operon 
OS=Staphylococcus aureus PE=3 SV=1 
239 5 0.86 
RSBW_
STAAS 
Serine-protein kinase rsbW OS=Staphylococcus aureus (strain 
MSSA476) GN=rsbW PE=3 SV=1 
87 1 0.86 
ROCA_
STAAS 
1-pyrroline-5-carboxylate dehydrogenase OS=Staphylococcus 
aureus (strain MSSA476) GN=rocA PE=3 SV=1 
2715 42 0.86 
DEOB_
STAAB 
Phosphopentomutase OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=deoB PE=3 SV=1 
493 9 0.86 
KTHY_S
TAAS 
Thymidylate kinase OS=Staphylococcus aureus (strain 
MSSA476) GN=tmk PE=3 SV=1 
85 2 0.86 
NANA_
STAAC 
N-acetylneuraminate lyase OS=Staphylococcus aureus (strain 
COL) GN=nanA PE=3 SV=1 
212 4 0.86 
GUAA_
STAAB 
GMP synthase [glutamine-hydrolyzing] OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=guaA PE=3 SV=1 
1249 19 0.86 
PPNK_
STAAB 
Probable inorganic polyphosphate/ATP-NAD kinase 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=ppnK PE=3 SV=1 
46 1 0.86 
THLA_S
TAAC 
Probable acetyl-CoA acyltransferase OS=Staphylococcus 
aureus (strain COL) GN=SACOL0426 PE=3 SV=1 
708 10 0.85 
SYM_S
TAAS 
Methionyl-tRNA synthetase OS=Staphylococcus aureus (strain 
MSSA476) GN=metG PE=3 SV=1 
859 14 0.85 
FEMA_
STAAC 
Aminoacyltransferase femA OS=Staphylococcus aureus (strain 
COL) GN=femA PE=3 SV=2 
414 5 0.85 
DEF_ST Peptide deformylase OS=Staphylococcus aureus (strain Mu50 / 237 3 0.85 
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AAM ATCC 700699) GN=def PE=1 SV=1 
Y941_S
TAAN 
UPF0356 protein SA0941 OS=Staphylococcus aureus (strain 
N315) GN=SA0941 PE=3 SV=2 
504 8 0.84 
Y1261_
STAAN 
UPF0403 protein SA1261 OS=Staphylococcus aureus (strain 
N315) GN=SA1261 PE=1 SV=1 
178 2 0.84 
SYW_S
TAAR 
Tryptophanyl-tRNA synthetase OS=Staphylococcus aureus 
(strain MRSA252) GN=trpS PE=3 SV=1 
284 5 0.84 
Y724_S
TAAB 
Epimerase family protein SAB0724c OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=SAB0724c PE=3 
SV=1 
165 2 0.83 
AHPC_
STAAB 
Alkyl hydroperoxide reductase subunit C OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=ahpC PE=3 SV=1 
1378 19 0.83 
GCP_S
TAAC 
Probable O-sialoglycoprotein endopeptidase 
OS=Staphylococcus aureus (strain COL) GN=gcp PE=3 SV=1 
59 1 0.83 
RELA_S
TAAR 
GTP pyrophosphokinase OS=Staphylococcus aureus (strain 
MRSA252) GN=relA PE=3 SV=1 
212 4 0.83 
MGRA_
STAAC 
HTH-type transcriptional regulator mgrA OS=Staphylococcus 
aureus (strain COL) GN=mgrA PE=3 SV=3 
297 4 0.83 
Y1592_
STAAR 
UPF0403 protein SAR1592 OS=Staphylococcus aureus (strain 
MRSA252) GN=SAR1592 PE=3 SV=1 
175 3 0.82 
GTAB_
STAAC 
UTP--glucose-1-phosphate uridylyltransferase 
OS=Staphylococcus aureus (strain COL) GN=gtaB PE=3 SV=1 
202 4 0.82 
Y1438_
STAAR 
DegV domain-containing protein SAR1438 OS=Staphylococcus 
aureus (strain MRSA252) GN=SAR1438 PE=4 SV=1 
377 4 0.82 
PUTP_S
TAAU 
Sodium/proline symporter OS=Staphylococcus aureus 
GN=putP PE=3 SV=2 
77 1 0.82 
Y1532_
STAAN 
Putative universal stress protein SA1532 OS=Staphylococcus 
aureus (strain N315) GN=SA1532 PE=1 SV=1 
716 11 0.81 
GSA1_S
TAAB 
Glutamate-1-semialdehyde 2,1-aminomutase 1 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=hemL1 PE=3 SV=1 
327 6 0.81 
LUXS_S
TAAC 
S-ribosylhomocysteine lyase OS=Staphylococcus aureus 
(strain COL) GN=luxS PE=3 SV=1 
168 3 0.81 
RSMH_
STAAM 
Ribosomal RNA small subunit methyltransferase H 
OS=Staphylococcus aureus (strain Mu50 / ATCC 700699) 
GN=rsmH PE=1 SV=1 
269 4 0.81 
METN2_ Methionine import ATP-binding protein MetN 2 
OS=Staphylococcus aureus (strain USA300) GN=metN2 PE=3 
76 2 0.81 
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STAA3 SV=1 
TPIS_S
TAAC 
Triosephosphate isomerase OS=Staphylococcus aureus (strain 
COL) GN=tpiA PE=3 SV=1 
1154 18 0.80 
URTF_S
TAAM 
Probable uridylyltransferase SAV2171 OS=Staphylococcus 
aureus (strain Mu50 / ATCC 700699) GN=SAV2171 PE=1 
SV=1 
199 4 0.80 
PTGA_
STAAS 
Glucose-specific phosphotransferase enzyme IIA component 
OS=Staphylococcus aureus (strain MSSA476) GN=crr PE=3 
SV=1 
313 5 0.80 
AROC_
STAAS 
Chorismate synthase OS=Staphylococcus aureus (strain 
MSSA476) GN=aroC PE=3 SV=1 
231 4 0.80 
PCRA_
STAAR 
ATP-dependent DNA helicase pcrA OS=Staphylococcus 
aureus (strain MRSA252) GN=pcrA PE=3 SV=1 
220 5 0.80 
DNAA_
STAAR 
Chromosomal replication initiator protein dnaA 
OS=Staphylococcus aureus (strain MRSA252) GN=dnaA PE=3 
SV=1 
139 3 0.80 
G3P1_S
TAAC 
Glyceraldehyde-3-phosphate dehydrogenase 1 
OS=Staphylococcus aureus (strain COL) GN=gapA1 PE=3 
SV=1 
2098 29 0.80 
HIS8_S
TAAR 
Histidinol-phosphate aminotransferase OS=Staphylococcus 
aureus (strain MRSA252) GN=hisC PE=3 SV=1 
77 1 0.79 
SYFA_S
TAAB 
Phenylalanyl-tRNA synthetase alpha chain 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=pheS PE=3 SV=1 
171 4 0.79 
RECA_
STAAB 
Protein recA OS=Staphylococcus aureus (strain bovine RF122 
/ ET3-1) GN=recA PE=3 SV=1 
445 6 0.79 
Y873_S
TAAN 
UPF0477 protein SA0873 OS=Staphylococcus aureus (strain 
N315) GN=SA0873 PE=1 SV=1 
392 8 0.79 
THIO_S
TAAB 
Thioredoxin OS=Staphylococcus aureus (strain bovine RF122 / 
ET3-1) GN=trxA PE=3 SV=1 
1086 16 0.79 
MNMG_
STAAM 
tRNA uridine 5-carboxymethylaminomethyl modification 
enzyme mnmG OS=Staphylococcus aureus (strain Mu50 / 
ATCC 700699) GN=mnmG PE=1 SV=1 
375 7 0.79 
ODPB_
STAAM 
Pyruvate dehydrogenase E1 component subunit beta 
OS=Staphylococcus aureus (strain Mu50 / ATCC 700699) 
GN=pdhB PE=1 SV=1 
1634 23 0.79 
ODO2_
STAA3 
Dihydrolipoyllysine-residue succinyltransferase component of 
2-oxoglutarate dehydrogenase complex OS=Staphylococcus 
aureus (strain USA300) GN=odhB PE=3 SV=1 
1472 21 0.78! 
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RL7_ST
AA1 
50S ribosomal protein L7/L12 OS=Staphylococcus aureus 
(strain Mu3 / ATCC 700698) GN=rplL PE=3 SV=1 
1014 10 0.78 
GLMU_
STAAB 
Bifunctional protein glmU OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=glmU PE=3 SV=2 
188 3 0.77 
K6PF_S
TAA2 
6-phosphofructokinase OS=Staphylococcus aureus (strain 
JH1) GN=pfkA PE=3 SV=1 
555 8 0.77 
CODY_
STAAB 
GTP-sensing transcriptional pleiotropic repressor codY 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=codY PE=3 SV=1 
480 7 0.77 
RRF_ST
AAB 
Ribosome-recycling factor OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=frr PE=3 SV=1 
406 9 0.77 
ALD1_S
TAAR 
Putative aldehyde dehydrogenase SAR2210 
OS=Staphylococcus aureus (strain MRSA252) GN=SAR2210 
PE=3 SV=1 
575 10 0.77 
EBPS_S
TAAS 
Elastin-binding protein ebpS OS=Staphylococcus aureus 
(strain MSSA476) GN=ebpS PE=3 SV=3 
303 3 0.77 
PLSY_S
TAAM 
Glycerol-3-phosphate acyltransferase OS=Staphylococcus 
aureus (strain Mu50 / ATCC 700699) GN=plsY PE=3 SV=1 
72 1 0.77 
PTG3C_
STAAR 
PTS system glucose-specific EIICBA component 
OS=Staphylococcus aureus (strain MRSA252) GN=ptsG PE=3 
SV=1 
147 3 0.77 
TPX_ST
AAC 
Probable thiol peroxidase OS=Staphylococcus aureus (strain 
COL) GN=tpx PE=3 SV=1 
609 8 0.77 
OHRL_
STAAS 
Organic hydroperoxide resistance protein-like 
OS=Staphylococcus aureus (strain MSSA476) GN=SAS0768 
PE=3 SV=1 
50 1 0.77 
MOAC_
STAAM 
Molybdenum cofactor biosynthesis protein C 
OS=Staphylococcus aureus (strain Mu50 / ATCC 700699) 
GN=moaC PE=3 SV=1 
60 1 0.77 
GSA2_S
TAA1 
Glutamate-1-semialdehyde 2,1-aminomutase 2 
OS=Staphylococcus aureus (strain Mu3 / ATCC 700698) 
GN=hemL2 PE=3 SV=1 
288 5 0.77 
TRMHL
_STAA
M 
Putative trmH family tRNA/rRNA methyltransferase 
OS=Staphylococcus aureus (strain Mu50 / ATCC 700699) 
GN=SAV0531 PE=1 SV=1 
76 1 0.77 
HSLU_S
TAAC 
ATP-dependent protease ATPase subunit HslU 
OS=Staphylococcus aureus (strain COL) GN=hslU PE=3 SV=1 
303 5 0.76 
Y197A_
STAAN 
UPF0457 protein SA1975.1 OS=Staphylococcus aureus (strain 
N315) GN=SA1975.1 PE=1 SV=1 
481 8 0.76 
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BSAA_
STAAC 
Glutathione peroxidase homolog BsaA OS=Staphylococcus 
aureus (strain COL) GN=bsaA PE=3 SV=1 
179 4 0.76 
PPI1_S
TAA3 
Putative peptidyl-prolyl cis-trans isomerase 
OS=Staphylococcus aureus (strain USA300) 
GN=SAUSA300_0857 PE=3 SV=1 
619 11 0.76 
Y1445_
STAAB 
UPF0365 protein SAB1445c OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=SAB1445c PE=3 SV=1 
738 10 0.76 
Y1019_
STAAN 
Uncharacterized N-acetyltransferase SA1019 
OS=Staphylococcus aureus (strain N315) GN=SA1019 PE=1 
SV=1 
276 4 0.75 
HCHA_
STAAC 
Chaperone protein hchA OS=Staphylococcus aureus (strain 
COL) GN=hchA PE=3 SV=1 
613 9 0.75 
Y2572_
STAAS 
UPF0312 protein SAS2572 OS=Staphylococcus aureus (strain 
MSSA476) GN=SAS2572 PE=3 SV=1 
247 1 0.74 
Y361_S
TAAW 
Uncharacterized protein MW0361 OS=Staphylococcus aureus 
(strain MW2) GN=MW0361 PE=4 SV=1 
501 7 0.74 
PDP_ST
AAC 
Pyrimidine-nucleoside phosphorylase OS=Staphylococcus 
aureus (strain COL) GN=pdp PE=1 SV=1 
903 12 0.74 
RSBV_
STAAC 
Anti-sigma-B factor antagonist OS=Staphylococcus aureus 
(strain COL) GN=rsbV PE=3 SV=2 
118 2 0.73 
Y1445_
STAAN 
UPF0297 protein SA1445 OS=Staphylococcus aureus (strain 
N315) GN=SA1445 PE=1 SV=1 
164 3 0.73 
OAT2_S
TAAC 
Ornithine aminotransferase 2 OS=Staphylococcus aureus 
(strain COL) GN=rocD2 PE=3 SV=1 
1228 18 0.73 
NFRA_
STAAS 
NADPH-dependent oxidoreductase OS=Staphylococcus 
aureus (strain MSSA476) GN=nfrA PE=3 SV=1 
79 1 0.73 
Y1508_
STAAS 
Putative metalloprotease SAS1508 OS=Staphylococcus aureus 
(strain MSSA476) GN=SAS1508 PE=3 SV=1 
102 2 0.70 
FEMB_
STAAW 
Aminoacyltransferase femB OS=Staphylococcus aureus (strain 
MW2) GN=femB PE=3 SV=1 
125 1 0.70 
ALF1_S
TAAS 
Fructose-bisphosphate aldolase class 1 OS=Staphylococcus 
aureus (strain MSSA476) GN=fda PE=3 SV=3 
1406 19 0.70 
GPSB_
STAAB 
Cell cycle protein gpsB OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=gpsB PE=3 SV=1 
305 5 0.70 
DBH_S
TAAC 
DNA-binding protein HU OS=Staphylococcus aureus (strain 
COL) GN=hup PE=3 SV=1 
1070 12 0.70 
ROT_ST HTH-type transcriptional regulator rot OS=Staphylococcus 267 4 0.70 
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AA8 aureus (strain NCTC 8325) GN=rot PE=3 SV=2 
ALDA_
STAAS 
Putative aldehyde dehydrogenase AldA OS=Staphylococcus 
aureus (strain MSSA476) GN=aldA PE=3 SV=1 
2032 28 0.69 
SODM2
_STAA
B 
Superoxide dismutase [Mn/Fe] 2 OS=Staphylococcus aureus 
(strain bovine RF122 / ET3-1) GN=sodM PE=3 SV=1 
101 2 0.69 
rndY160
8_STAA
3 
UPF0758 protein SAUSA300_1608 OS=Staphylococcus 
aureus (strain USA300) GN=SAUSA300_1608 PE=3 SV=1 
45 1 0.69 
CNA_S
TAAU 
Collagen adhesin OS=Staphylococcus aureus GN=cna PE=1 
SV=1 
165 3 0.68 
P5CR_S
TAAM 
Pyrroline-5-carboxylate reductase OS=Staphylococcus aureus 
(strain Mu50 / ATCC 700699) GN=proC PE=1 SV=1 
130 2 0.68 
COAW_
STAAM 
Type II pantothenate kinase OS=Staphylococcus aureus (strain 
Mu50 / ATCC 700699) GN=coaW PE=1 SV=1 
49 1 0.67 
IMDH_S
TAAW 
Inosine-5'-monophosphate dehydrogenase 
OS=Staphylococcus aureus (strain MW2) GN=guaB PE=3 
SV=1 
2199 34 0.65 
DLTC_S
TAAB 
D-alanine--poly(phosphoribitol) ligase subunit 2 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=dltC PE=3 SV=1 
333 3 0.65 
GATC_
STAAB 
Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=gatC PE=3 SV=1 
248 4 0.65 
SARS_
STAAR 
HTH-type transcriptional regulator sarS OS=Staphylococcus 
aureus (strain MRSA252) GN=sarS PE=3 SV=1 
213 5 0.64 
Y1566_
STAAB 
UPF0173 metal-dependent hydrolase SAB1566c 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=SAB1566c PE=3 SV=1 
209 3 0.63 
Y1186_
STAAN 
Uncharacterized protein SA1186 OS=Staphylococcus aureus 
(strain N315) GN=SA1186 PE=1 SV=1 
75 2 0.61 
GREA_
STAAB 
Transcription elongation factor greA OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=greA PE=3 SV=1 
556 8 0.61 
TYSY_S
TAAM 
Thymidylate synthase OS=Staphylococcus aureus (strain Mu50 
/ ATCC 700699) GN=thyA PE=1 SV=1 
57 1 0.60 
Y863_S
TAAN 
UPF0738 protein SA0863 OS=Staphylococcus aureus (strain 
N315) GN=SA0863 PE=3 SV=1 
85 2 0.60 
Y2548_ Uncharacterized protein MW2548 OS=Staphylococcus aureus 66 1 0.59 
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STAAW (strain MW2) GN=MW2548 PE=4 SV=1 
CLPL_S
TAAS 
ATP-dependent Clp protease ATP-binding subunit clpL 
OS=Staphylococcus aureus (strain MSSA476) GN=clpL PE=3 
SV=1 
1099 17 0.58 
AGRA_
STAAC 
Accessory gene regulator A OS=Staphylococcus aureus (strain 
COL) GN=agrA PE=3 SV=1 
123 2 0.57 
PTHP_S
TAAC 
Phosphocarrier protein HPr OS=Staphylococcus aureus (strain 
COL) GN=ptsH PE=3 SV=1 
170 1 0.57 
NAGB_
STAAB 
Glucosamine-6-phosphate deaminase OS=Staphylococcus 
aureus (strain bovine RF122 / ET3-1) GN=nagB PE=3 SV=1 
44 1 0.57 
RPOE_
STAAC 
Probable DNA-directed RNA polymerase subunit delta 
OS=Staphylococcus aureus (strain COL) GN=rpoE PE=3 SV=1 
655 8 0.55 
Y1663_
STAAN 
UPF0342 protein SA1663 OS=Staphylococcus aureus (strain 
N315) GN=SA1663 PE=1 SV=1 
1170 14 0.55 
Y2259_
STAAS 
Uncharacterized lipoprotein SAS2259 OS=Staphylococcus 
aureus (strain MSSA476) GN=SAS2259 PE=4 SV=1 
191 3 0.55 
UP355_
STAAC 
UPF0355 protein SACOL0457 OS=Staphylococcus aureus 
(strain COL) GN=SACOL0457 PE=3 SV=1 
388 6 0.53 
Y1692_
STAAN 
Uncharacterized protein SA1692 OS=Staphylococcus aureus 
(strain N315) GN=SA1692 PE=3 SV=1 
288 4 0.52 
Y1696_
STAAN 
UPF0435 protein SA1696 OS=Staphylococcus aureus (strain 
N315) GN=SA1696 PE=1 SV=1 
279 3 0.51 
XPT_ST
AAC 
Xanthine phosphoribosyltransferase OS=Staphylococcus 
aureus (strain COL) GN=xpt PE=3 SV=1 
378 6 0.48 
LTAS_S
TAAB 
Glycerol phosphate lipoteichoic acid synthase 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=ltaS PE=3 SV=1 
122 2 0.48 
SLE1_S
TAA3 
N-acetylmuramoyl-L-alanine amidase sle1 OS=Staphylococcus 
aureus (strain USA300) GN=sle1 PE=3 SV=1 
207 4 0.47 
ISAB_S
TAAB 
Immunodominant staphylococcal antigen B 
OS=Staphylococcus aureus (strain bovine RF122 / ET3-1) 
GN=isaB PE=3 SV=1 
203 3 0.44 
SBI_ST
AAM 
Immunoglobulin-binding protein sbi OS=Staphylococcus aureus 
(strain Mu50 / ATCC 700699) GN=sbi PE=1 SV=2 
243 4 0.42 
ACP_ST
AAB 
Acyl carrier protein OS=Staphylococcus aureus (strain bovine 
RF122 / ET3-1) GN=acpP PE=3 SV=1 
347 4 0.40 
SP5G_S Putative septation protein spoVG OS=Staphylococcus aureus 157 3 0.40 
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TAA2 (strain JH1) GN=spoVG PE=3 SV=1 
HPS_ST
AAR 
3-hexulose-6-phosphate synthase OS=Staphylococcus aureus 
(strain MRSA252) GN=SAR0574 PE=3 SV=1 
691 9 0.40 
COPZ_
STAAC 
Copper chaperone copZ OS=Staphylococcus aureus (strain 
COL) GN=copZ PE=3 SV=1 
131 2 0.38 
GCSH_
STAAM 
Glycine cleavage system H protein OS=Staphylococcus aureus 
(strain Mu50 / ATCC 700699) GN=gcvH PE=3 SV=1 
514 8 0.36 
Y2467_
STAAS 
Uncharacterized hydrolase SAS2467 OS=Staphylococcus 
aureus (strain MSSA476) GN=SAS2467 PE=3 SV=1 
78 1 0.36 
Y2370_
STAAS 
Uncharacterized oxidoreductase SAS2370 OS=Staphylococcus 
aureus (strain MSSA476) GN=SAS2370 PE=3 SV=1 
145 2 0.34 
Y1443_
STAAN 
UPF0473 protein SA1443 OS=Staphylococcus aureus (strain 
N315) GN=SA1443 PE=1 SV=1 
246 4 0.33 
ATL_ST
AAS 
Bifunctional autolysin OS=Staphylococcus aureus (strain 
MSSA476) GN=atl PE=3 SV=1 
2879 43 0.32 
ASP23_
STAA3 
Alkaline shock protein 23 OS=Staphylococcus aureus (strain 
USA300) GN=asp23 PE=3 SV=1 
1496 22 0.27 
SSAA2_
STAAC 
Staphylococcal secretory antigen ssaA2 OS=Staphylococcus 
aureus (strain COL) GN=ssaA2 PE=3 SV=1 
1049 12 0.26 
LIP2_ST
AAC 
Lipase 2 OS=Staphylococcus aureus (strain COL) GN=lip2 
PE=3 SV=2 
122 3 0.23 
SDRE_
STAAS 
Serine-aspartate repeat-containing protein E 
OS=Staphylococcus aureus (strain MSSA476) GN=sdrE PE=3 
SV=1 
66 1 0.20 
ESXA_S
TAAC 
Virulence factor esxA OS=Staphylococcus aureus (strain COL) 
GN=esxA PE=3 SV=1 
497 5 0.18 
ISAA_S
TAAC 
Probable transglycosylase isaA OS=Staphylococcus aureus 
(strain COL) GN=isaA PE=1 SV=1 
320 4 0.16 
CSPA_
STAAB 
Cold shock protein cspA OS=Staphylococcus aureus (strain 
bovine RF122 / ET3-1) GN=cspA PE=3 SV=1 
290 4 0.16! 
SPA_ST
AA8 
Immunoglobulin G-binding protein A OS=Staphylococcus 
aureus (strain NCTC 8325) GN=spa PE=1 SV=3 
2521 34 0.14 
CLFA_S
TAAS 
Clumping factor A OS=Staphylococcus aureus (strain 
MSSA476) GN=clfA PE=3 SV=1 
83 1 0.12 
Y772_S
TAAN 
UPF0337 protein SA0772 OS=Staphylococcus aureus (strain 
N315) GN=SA0772 PE=1 SV=1 
267 4 0.10 
Appendix 
118 
ZDH1_S
TAAC 
Zinc-type alcohol dehydrogenase-like protein SACOL2177 
OS=Staphylococcus aureus (strain COL) GN=SACOL2177 
PE=3 SV=1 
50 1 
Table 8 : Nano LC-MALDI analysis data , presenting identified proteins, with 
their accession code, Nr of peptide hits with matching sequences and ratio of 
protein expression in ErCu to protein expression in MSSA476 
